| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2026―May―16 |
SARS-CoV-2 aerosols: A physical bridge linking upper respiratory infection to lung pathology - A pathological transmission hypothesis |
Qiru Shi |
| 2 |
[GO] |
2026―Jan―17 |
Moderate-intensity exercise as a preventive strategy against dopaminergic dysfunction in Long COVID: A mechanistic hypothesis |
Bogdan-Alexandru Hagiu |
| 3 |
[GO] |
2026―Jan―02 |
Targeting conserved dynamic regions of SARS-CoV-2 spike protein identified by normal mode analysis for broad-spectrum antiviral therapy |
Junhong Lü |
| 4 |
[GO] |
2025―Dec―24 |
Long COVID may be treatable with noradrenergic transmission reducing drugs |
Paul J. Fitzgerald |
| 5 |
[GO] |
2025―Dec―24 |
Creatine insufficiency as an energetic amplifier of brainstem dysfunction in ME/CFS and long COVID |
Nikola Todorovic |
| 6 |
[GO] |
2025―Nov―20 |
Brainstem dysfunction as a potential etiology of ME/CFS and long COVID: A mechanical basis |
Jeffrey D. Wood, Thomas F. Varley, Jacob Hartman, Nick Melia, David L. Kaufman, Tess Falor |
| 7 |
[GO] |
2025―Sep―14 |
Cigarette smoke as a superspreading vector of SARS-CoV-2, measles virus, and influenza virus: A hypothesis on virus-laden aerosol formation and transport |
Donghyun Kim |
| 8 |
[GO] |
2025―Jul―15 |
Long Vax is delayed onset Long COVID |
Thomas Bunker |
| 9 |
[GO] |
2025―Jun―06 |
Skeletal muscle oxygen tension as a measure of COVID-19 disease severity and predictor of disease progression |
Neil Stacey, Danella Oelofse, Joseph Palos, Luke Pieterse, Zoë Da Silva, Nidal Boorany, Suné Toerien, Cole Potgieter |
| 10 |
[GO] |
2025―Mar―01 |
Corrigendum to “A hypothesis linking the Renin-Angiotensin, Kallikrein-Kinin systems, and disseminated coagulation in Covid-19” [Med. Hypothesis 192 (2024) 111488] |
Paula Fernanda Ribas Neves, Lisiê Valéria Paz, Andrea Wieck, Léder Leal Xavier |
| 11 |
[GO] |
2025―Feb―17 |
Exploring dual applications of gliptins: A potential host-targeted strategy for diabetes and COVID-19 co-morbidity |
A. Nag, Y.P. Baid, M. Tyagi |
| 12 |
[GO] |
2025―Jan―06 |
Calcitonin gene-related peptide-induced central sensitization: A hypothesis for long COVID symptoms |
Ella J. Lee, Cynthia Tsang, Martha Lucía Gutiérrez Pérez, Mehdi Abouzari, Hamid R. Djalilian |
| 13 |
[GO] |
2024―Nov―08 |
COVID-19 era and GLP-1 RA era: Is it a renaissance when the dusk of global tragedy co-occurring with the dawn of magical remedy? |
Deepak Gupta, Berhane Seyoum, Sarwan Kumar, Shushovan Chakrabortty |
| 14 |
[GO] |
2024―Sep―23 |
A hypothesis linking the renin-angiotensin, kallikrein-kinin systems, and disseminated coagulation in covid-19 |
Paula Fernanda Ribas Neves, Lisiê Valéria Paz, Andrea Wieck, Léder Leal Xavier |
| 15 |
[GO] |
2024―Jun―12 |
NIoBReTH: A novel integrative paradigm of protection against SARS-CoV-2 and other airborne pathogens with fewer socioeconomic constraints |
Qianxi Li, Yulin Ling, Guanxu Chen, Shangqiu Ye |
| 16 |
[GO] |
2024―Apr―30 |
Can SLU-PP-332 be a new drug to prevent COVID-19? |
B.-A. Hagiu |
| 17 |
[GO] |
2024―Apr―24 |
Determinants of long-lasting postviral COVID-19 and non-COVID-19 olfactory Dysfunction: The sanctuary theory |
Jerome R. Lechien |
| 18 |
[GO] |
2024―Feb―18 |
COVID-19 infection activates genetically predisposed risk pathways in lungs to escalate T1D development |
Daniel Ho, Justin M. O'Sullivan |
| 19 |
[GO] |
2023―Oct―31 |
Long-term neurological implications of severe acute respiratory syndrome coronavirus 2 infections in neonates: Innate immune memory and chronic neuroinflammation |
Tatsuro Nobutoki |
| 20 |
[GO] |
2023―Oct―13 |
Brain fog in long COVID: A glutamatergic hypothesis with astrocyte dysfunction accounting for brain PET glucose hypometabolism |
Tatiana Horowitz, Luc Pellerin, Eduardo R. Zimmer, Eric Guedj |
| 21 |
[GO] |
2023―Oct―10 |
Molecular hydrogen as a potential adjuvant therapy for alleviating long COVID |
Nikola Todorovic, Sergej M. Ostojic |
| 22 |
[GO] |
2023―Mar―28 |
Will the increased use of ring lights during the coronavirus pandemic lead to a growing burden of macular degeneration? |
Jessica Stanhope, Philip Weinstein |
| 23 |
[GO] |
2023―Jan―27 |
Adipocytes in obesity: A perfect reservoir for SARS-CoV-2? |
JingJing Zhu, John P.H. Wilding, Ji Hu |
| 24 |
[GO] |
2022―Dec―16 |
Insulin may promote SARS-CoV-2 cell entry and replication in diabetes patients |
Wenwu Sun |
| 25 |
[GO] |
2022―Nov―18 |
Autophagy: A self-guard against SARS-CoV-2 |
Rafael Cardoso Maciel Costa Silva, Leonardo Holanda Travassos |
| 26 |
[GO] |
2022―Oct―27 |
Proposal for the use of an inhalation drug containing 2-5 oligoadenylates for treatment of COVID-19 |
Gernot Bruchelt, Jörn Treuner, Karlheinz Schmidt |
| 27 |
[GO] |
2022―Sep―21 |
Plasma fibrinogen: an important piece of the COVID-19 ICU delirium puzzle? |
Sarah Saxena, Alexandre-Raphael Wery, Adrian Khelif, Marie-Laure Nisolle, Christophe Lelubre, Mervyn Maze, Patrick Biston, Michael Piagnerelli |
| 28 |
[GO] |
2022―Sep―17 |
Tailored lipopeptide surfactants as potentially effective drugs to treat SARS-CoV-2 infection |
Davoud Biria |
| 29 |
[GO] |
2022―Sep―09 |
COVID-19 diverse outcomes: aggravated reinfection, type I Interferons and antibodies |
Rafael Cardoso Maciel Costa Silva, Christianne Bandeira-Melo, Heitor Afonso Paula Neto, André Macedo Vale, Leonardo Holanda Travassos |
| 30 |
[GO] |
2022―Aug―03 |
Can plant-derived anti-HIV compounds be used in COVID-19 cases? |
Diptimayee Das, Atala Bihari Jena, Antara Banerjee, Arun Kumar Radhakrishnan, Asim K. Duttaroy, Surajit Pathak |
| 31 |
[GO] |
2022―Jul―01 |
An alternative to airborne droplet transmission route of SARS-CoV-2, the feco-oral route, as a factor shaping COVID-19 pandemic |
Ryszard Targoński, Aleksandra Gąsecka, Adrian Prowancki, Radosław Targoński |
| 32 |
[GO] |
2022―Jun―13 |
Can Covid-19 be iatrogenically auto-transmitted through Combined Oropharengeal and Nasopharengeal Swabs Test With One Bar? |
Hakan Alagozlu |
| 33 |
[GO] |
2022―Jun―08 |
WITHDRAWN: Elevated histamine etiology model for most major vaccine associated adverse events including SARS-CoV-2 spike vaccines |
Darrell O. Ricke |
| 34 |
[GO] |
2022―May―20 |
Multifaceted efficacy of caspofungin against fungal infections in COVID-19 patients |
Kazuhiro Itoh, Hiroshi Tsutani, Hiromichi Iwasaki |
| 35 |
[GO] |
2022―Apr―15 |
Deconditioning in COVID-19 survivors with reduced exercise performance: A role for endothelial dysfunction? |
Pasquale Ambrosino, Mauro Maniscalco |
| 36 |
[GO] |
2022―Apr―15 |
Are Dyskeratosis Congenita Patients at Higher Risk of Symptomatic COVID-19? |
Saeed Dorgaleleh, Karim Naghipoor, Amir Hozhabrpour, Hassan Vahidnezhad |
| 37 |
[GO] |
2022―Apr―13 |
Marginal BH4 Deficiencies, iNOS, and Self-perpetuating Oxidative Stress in Post-acute Sequelae of Covid-19 |
William A. Villaume |
| 38 |
[GO] |
2022―Feb―25 |
Proposal for assessment of the predominant symptom and physical function in patients suffering from Long COVID |
Cristina Roldán-Jiménez, Antonio Ignacio Cuesta-Vargas |
| 39 |
[GO] |
2022―Feb―23 |
Calcitonin gene-related peptide: A biomarker for stroke in SARS-CoV-2 infection? |
Yassamine Ouerdane, Yahia Khlidj, Mohamed S. Attia, Rafik Korissi |
| 40 |
[GO] |
2022―Feb―22 |
Combatting future variants of SARS-CoV-2 using an in-silico peptide vaccine approach by targeting the spike protein |
Subhamoy Biswas, Sumanta Dey, Shreyans Chatterjee, Ashesh Nandy |
| 41 |
[GO] |
2022―Feb―22 |
Can COVID-19 vaccines relieve severe tension-type headache and migraine? |
Jordi González-Menacho, Mónica Villas-Roca, Helena Castañé, Jorge Joven, Jordi Camps, Simona Iftimie |
| 42 |
[GO] |
2022―Feb―22 |
Will the bone mineral density in postmenopausal women get worse during the COVID-19 pandemic? |
Yunzhong Cheng, Honghao Yang, Ziyang Liu, Yong Hai, Yuzeng Liu, Lijin Zhou |
| 43 |
[GO] |
2022―Feb―14 |
L-Methionine May Modulate the Assembly of SARS-CoV-2 by Interfering with the Mechanism of RNA Polymerase |
Maximo A. Benavides |
| 44 |
[GO] |
2022―Jan―25 |
Diethylcarbamazine as potential treatment of COVID-19 lung fibrosis |
Carlos Eduardo Medina-De la Garza, Armando Salvador Flores-Torres, Marisela García-Hernández, María de los Ángeles Castro-Corona |
| 45 |
[GO] |
2022―Jan―25 |
Copper acetate aerosols: a possible tool complementary to vaccination in fight against SARS-CoV-2 and variants replication |
Deloncle Roger, Guillard Olivier, Pineau Alain, Lesage Gérard |
| 46 |
[GO] |
2022―Jan―25 |
Mitochondrial hijacking: a potential mechanism for SARS-CoV-2 to impair female fertility |
Jun Sun, Qiong Liu, Xinling Zhang, Shu Dun, Li Liu |
| 47 |
[GO] |
2022―Jan―04 |
A one-step platform for screening high-efficient and minimal off-target CRISPR/Cas13 crRNAs to eradicate SARS-CoV-2 virus for treatment of COVID-19 patients |
Pu-Yu Li, San-Qiang Li, She-Gan Gao, Dao-Yin Dong |
| 48 |
[GO] |
2022―Jan―04 |
Restructuring the ONYX-015 adenovirus by using spike protein genes from SARS-CoV-2 and MERS-CoV: Possible implications in breast cancer treatment |
Hamendra Singh Parmar, Aakruti Nayak, Shreya Kataria, Versha Tripathi, Pooja Jaiswal, Pramod Kumar Gavel, Hem Chandra Jha, Shivani Bhagwat, Amit Kumar Dixit, Vladimir Lukashevich, Apurba Kumar Das, Rajesh Sharma |
| 49 |
[GO] |
2022―Jan―03 |
Bioluminescence and Ventilator-Associated Pneumonia caused by oral biofilm in ICU during COVID-19 -Is there a possible relationship? |
Betsy Joseph, Liviu Steier |
| 50 |
[GO] |
2022―Jan―03 |
Nanomedicine formulations for respiratory infections by inhalation delivery: Covid-19 and beyond |
Oron Zachar |
| 51 |
[GO] |
2022―Jan―03 |
Proposed mechanism for rare thrombotic events after use of some Covid-19 vaccines |
Peter A. Feldman |
| 52 |
[GO] |
2022―Jan―03 |
SARS-CoV-2 might transmit through the skin while the skin barrier function could be the mediator |
Qiannan Xu, Li Zhang, Lihong Chen, Xiaoqing Zhao, Xiaopan Wang, Mengyan Hu, Yunchen Le, Feng Xue, Xia Li, Jie Zheng |
| 53 |
[GO] |
2021―Dec―14 |
Nicotinic receptors as SARS-CoV-2 spike co-receptors? |
Valérian Dormoy, Jeanne-Marie Perotin, Philippe Gosset, Uwe Maskos, Myriam Polette, Gaëtan Deslée |
| 54 |
[GO] |
2021―Dec―09 |
Potential therapeutic effect of glucagon-like peptide-1 receptor agonists on COVID-19-induced pulmonary arterial hypertension |
Jong Han Lee |
| 55 |
[GO] |
2021―Nov―09 |
BPC 157 as Potential Treatment for COVID-19 |
Sarah A. Deek |
| 56 |
[GO] |
2021―Nov―09 |
Vitamin D may prevent COVID-19 induced pregnancy complication |
Ali Al-Kaleel, Lubna Al-Gailani, Mustafa Demir, Hatice Aygün |
| 57 |
[GO] |
2021―Oct―29 |
Deregulated kynurenine metabolism - An alternate hypothesis for COVID-19 associated anosmia |
Amit Jain |
| 58 |
[GO] |
2021―Oct―29 |
Deficient synthesis of melatonin in COVID-19 can impair the resistance of coronavirus patients to mucormycosis |
Amarnath Sen |
| 59 |
[GO] |
2021―Oct―21 |
Are there medium to short-term effects of the airborne pollutant PM2.5 determining the emergence of SARS-CoV-2 variants? |
Yves Muscat Baron |
| 60 |
[GO] |
2021―Oct―14 |
Models for SARS-CoV-2 Associated Thrombocytopenia associated with Hemophagocytic Histiocytes |
Darrell O. Ricke |
| 61 |
[GO] |
2021―Oct―14 |
Molecular docking of SARS-COV-2 Spike epitope sequences identifies heterodimeric peptide-protein complex formation with human Zo-1, TLR8 and brain specific glial proteins |
Subhajit Dasgupta, Mausumi Bandyopadhyay |
| 62 |
[GO] |
2021―Oct―11 |
Moderate exercise may prevent the development of severe forms of COVID-19, whereas high-intensity exercise may result in the opposite |
BA. Hagiu |
| 63 |
[GO] |
2021―Sep―21 |
Is digital necrosis in COVID-19 caused by neutrophil extracellular traps: potential therapeutic strategies |
Marian Simka |
| 64 |
[GO] |
2021―Sep―21 |
Rise and exacerbation of oral lichen planus in the background of SARS-CoV-2 infection |
Anubhuti Sood, Sreevatsan Raghavan, Puneet Batra, Karan Sharma, Aditya Talwar |
| 65 |
[GO] |
2021―Sep―15 |
Mucus targeting as a plausible approach to improve lung function in covid-19 patients |
Sarath S. Kumar, Aiswarya Binu, Aswathy.R. Devan, Lekshmi.R. Nath |
| 66 |
[GO] |
2021―Sep―13 |
Estimate of benefit attributable to wearing masks in chicago during the early days of the pandemic |
Damien G. Retzinger, Andrew C. Retzinger, Gregory S. Retzinger |
| 67 |
[GO] |
2021―Sep―09 |
High intelligence may exacerbate paediatric inflammatory response to SARS-CoV-2 infection |
Pauline McDonagh Hull, Bonnie M. Lashewicz, Marvin J Fritzler |
| 68 |
[GO] |
2021―Sep―04 |
FUTHER COMMENT ON ARTICLES PERTAINING TO: “Homocysteine as a potential predictor of cardiovascular risk in patients with COVID-19” |
Anne Berbert |
| 69 |
[GO] |
2021―Aug―21 |
Nutrition acquisition by human immunity, transient overnutrition and the cytokine storm in severe cases of COVID-19 |
Boxuan Yu, Ligen Yu, Daniel J. Klionsky |
| 70 |
[GO] |
2021―Aug―10 |
Prolactin and susceptibility to COVID-19 infection |
Fatemeh Mirzaei, Alireza Tavilani, Zahra Asefy, Ebrahim Abbasi |
| 71 |
[GO] |
2021―Aug―09 |
Drug-repurposing against COVID-19 by targeting a key signaling pathway: An in silico study |
Ki Kwang Oh, Md. Adnan, Dong Ha Cho |
| 72 |
[GO] |
2021―Aug―05 |
The use of negative oxygen ion clusters [O2-(H2O)n] and bicarbonate ions [HCO3-] as the supportive treatment of COVID-19 infections: a possibility |
Ravindra V. Badhe, Sonali S. Nipate |
| 73 |
[GO] |
2021―Aug―05 |
Supportive therapy during COVID-19: the proposed mechanism of short-chain fatty acids to prevent cytokine storm and multi-organ failure |
M. Jardou, R. Lawson |
| 74 |
[GO] |
2021―Aug―03 |
Age, obesity and hyperglycaemia: Activation of innate immunity initiates a series of molecular interactions involving anionic surfaces leading to covid-19 morbidity and mortality |
Charles N. Birts, David C. Wilton |
| 75 |
[GO] |
2021―Jul―29 |
Barrier resuscitation by lay rescuers during COVID-19 pandemic |
Wolfgang Lederer, Markus Isser |
| 76 |
[GO] |
2021―Jul―06 |
TLR4 Involvement in COVID-19 Predicts a Seasonal Risk of Aspergillus Superinfection: A Call for Vigilance |
Andrew C. Retzinger, Gregory S. Retzinger |
| 77 |
[GO] |
2021―Jul―06 |
B cell receptor (BCR) guided Mechanotransduction: Critical hypothesis to instruct SARS-CoV-2 specific B cells to trigger proximal signalling and antibody reshaping |
Kabeer Haneef, Abdul Ghaffar Memon, Rabia Saleem, Farwa Batool, Mohd Sadeeq |
| 78 |
[GO] |
2021―Jul―06 |
Highly expressed ACE-2 receptors during pregnancy: A protective factor for SARS-COV-2 infection? |
Ernesto Antonio Figueiro-Filho, Sebastian R. Hobson, Dan Farine, Mark H. Yudin |
| 79 |
[GO] |
2021―Jun―24 |
Carpal, cubital or tarsal tunnel syndrome after SARS-CoV-2 infection: a causal link? |
Luca Roncati, Greta Gianotti, Davide Gravina, Giovanna Attolini, Giuliana Zanelli, Norman Della Rosa, Roberto Adani |
| 80 |
[GO] |
2021―Jun―09 |
Diseased Lungs May Hinder COVID-19 Development: A Possible Reason for the Low Prevalence of COPD in COVID-19 Patients |
Shin Jie Yong |
| 81 |
[GO] |
2021―Jun―06 |
Does serotonin deficiency lead to anosmia, ageusia, dysfunctional chemesthesis and increaed severity of illness in COVID-19? |
Amarnath Sen |
| 82 |
[GO] |
2021―Jun―05 |
Early Multidrug Treatment of SARS-CoV-2 Infection (COVID-19) and Reduced Mortality Among Nursing Home Residents |
Paul E Alexander, Robin Armstrong, George Fareed, John Lotus, Ramin Oskoui, Chad Prodromos, Harvey A. Risch, Howard C. Tenenbaum, Craig M. Wax, Parvez Dara, Peter A. McCullough |
| 83 |
[GO] |
2021―Jun―04 |
Should we screen Eastern Mediterranean COVID-19 patients for inherited thrombophilia? |
Georges El Hasbani, Ali T Taher |
| 84 |
[GO] |
2021―Jun―01 |
A tale of two diseases: Sarcoidosis, COVID-19 and new therapeutic options with dual RAS inhibition and tetanus-diphtheria vaccine |
Demircan Ozbalci |
| 85 |
[GO] |
2021―May―20 |
Decorin as a possible strategy for the amelioration of COVID-19 |
Prince Allawadhi, Vishakha Singh, Isha Khurana, Pushkar Singh Rawat, Akshata Patangrao Renushe, Amit Khurana, Umashanker Navik, Sachin Allwadhi, Satish Kumar, Anil Kumar Banothu, Kala Kumar Bharani |
| 86 |
[GO] |
2021―May―12 |
Hypothesis for renin-angiotensin inhibitor mitigation of COVID-19 |
Henry Sackin |
| 87 |
[GO] |
2021―May―12 |
Retraction notice to “Facemasks in the COVID-19 era: A health hypothesis” [Medical Hypotheses 146 (2021) 5] |
Baruch Vainshelboim |
| 88 |
[GO] |
2021―Apr―09 |
Application of intravenous immunoglobulin (IVIG) to modulate inflammation in critical COVID-19 - A theoretical perspective |
Ahmed Yaqinuddin, Ayesha Rahman Ambia, Tasnim Atef Elgazzar, Maha bint Mishari AlSaud, Junaid Kashir |
| 89 |
[GO] |
2021―Mar―30 |
The Role of Carbohydrate Antigen 125 in COVID-19 |
Esra Dökümcü |
| 90 |
[GO] |
2021―Mar―30 |
Testicles, adipose organ and heart: a new axis in the management of SARS-CoV-2? |
Alexander Bertuccioli, Marco Cardinali, Francesco Di Pierro |
| 91 |
[GO] |
2021―Mar―30 |
Role of NLRP3 Inflammasome in COVID-19 and Periodontitis: Possible Protective Effect of Melatonin |
Ahmet Özer Şehirli, Umut Aksoy, Revan Birke Koca-Ünsal, Serkan Sayiner |
| 92 |
[GO] |
2021―Mar―25 |
Could SARS-CoV-2 blocking of ACE2 in endothelial cells result in upregulation of CX3CL1, promoting thrombosis in COVID-19 patients? |
Selma Rivas-Fuentes, Víctor Julián Valdés, Blanca Espinosa, Patricia Gorocica-Rosete, Alfonso Salgado-Aguayo |
| 93 |
[GO] |
2021―Mar―25 |
Strengthening CoViD-19 therapy via combinations of RAS modulators |
Veselina V. Uzunova, Angel Todev, Jacqueline Zarkos, Daniel Addai, Julian Ananiev, Pavel Rashev, Radostina Alexandrova, Anna Tolekova |
| 94 |
[GO] |
2021―Mar―23 |
Methylene blue: subduing the post COVID-19 blues! |
Rohan Magoon, Noopur Bansal, Armaanjeet Singh, Ramesh Kashav |
| 95 |
[GO] |
2021―Mar―23 |
Anticholinergic drugs versus preprocedural mouth rinses for reduction of SARS-CoV-2 load in dental aerosols |
Gargi S Sarode, Sachin C Sarode, Shankargouda Patil |
| 96 |
[GO] |
2021―Mar―23 |
Endotheliitis, Endothelin, and Endothelin Receptor Blockers in COVID-19 |
Devang K. Sanghavi, Anoop Titus, Thomas R. Caulfield, W. David Freeman |
| 97 |
[GO] |
2021―Mar―23 |
Are prion proteins and magnetite involved in the immune cells memory system connected to the covid-19? |
Fredrik C. Størmer |
| 98 |
[GO] |
2021―Mar―23 |
Aminoglycosides and their potential as SARS-CoV-2 antivirals |
Nevio Cimolai |
| 99 |
[GO] |
2021―Mar―07 |
Etoricoxib may inhibit cytokine storm to treat COVID-19 |
Ruo Wang |
| 100 |
[GO] |
2021―Feb―21 |
Folic acid as placebo in controlled clinical trials of hydroxychloroquine prophylaxis in COVID-19: is it scientifically justifiable? |
Hardeep Kaur, Phulen Sarma, Anusuya Bhattacharyya, Manisha Prajapat, Subodh Kumar, Ajay Prakash, Bikash Medhi |
| 101 |
[GO] |
2021―Feb―19 |
COVID-19, colchicine and glycemia |
Ioannis Ilias, Charalambos Milionis |
| 102 |
[GO] |
2021―Feb―19 |
Autism spectrum disorder patients may be susceptible to COVID-19 disease due to deficiency in melatonin |
Gregory M Brown, Ramanujam Karthikeyan, Seithikurippu R. Pandi-Perumal, Daniel P. Cardinali |
| 103 |
[GO] |
2021―Feb―19 |
COVID-19-related Arrhythmias and The Possible Effects of Ranolazine |
Ugochukwu Chukwunyere, Ahmet Ozer Sehirli, Nurettin Abacioglu |
| 104 |
[GO] |
2021―Feb―19 |
COVID-19: A Methyl-Group Assault? |
Andrew Mccaddon, Björn Regland |
| 105 |
[GO] |
2021―Feb―17 |
Persistent SARS-2 infections contribute to long COVID-19 |
John J.L. Jacobs |
| 106 |
[GO] |
2021―Feb―17 |
Old Drug, New Trick? The Rationale for the Treatment of COVID-19 with Activated Protein C |
Steven B. Pestka |
| 107 |
[GO] |
2021―Feb―15 |
Clofazimine: A Potential Therapeutic Option for Severe COVID-19 |
Areej Mohamed Ateya |
| 108 |
[GO] |
2021―Feb―15 |
Can bilirubin nanomedicine become a hope for the management of COVID-19? |
Isha Khurana, Prince Allawadhi, Amit Khurana, Amit Kumar Srivastava, Umashanker Navik, Anil Kumar Banothu, Kala Kumar Bharani |
| 109 |
[GO] |
2021―Feb―10 |
Pulmonary lipid modulation: a possible therapeutic target for SARS-CoV-2 infection |
Claudia Mandato, Pietro Vajro |
| 110 |
[GO] |
2021―Feb―09 |
A genetic insight into vitamin D binding protein and COVID-19 |
Mona Alshahawey |
| 111 |
[GO] |
2021―Jan―28 |
Airways to heaven: caution needed when exercising during COVID-19 |
Lucio Della Guardia, Roberto Codella |
| 112 |
[GO] |
2021―Jan―28 |
The potential use of lactate blockers for the prevention of COVID-19 worst outcome, insights from exercise immunology |
Antoine Fakhry AbdelMassih, Rahma Menshawey, Rafeef Hozaien, Aya Kamel, Fady Mishriky, Reem J. Husseiny, Aia Mohamed Hanoura, Elaria Yacoub, Nada AlShehry, Esraa Menshawey, Nadine El-Husseiny, Reem Yasser, Mariem Arsanyous, Lauren Nathan, Mahmoud Seyam, Doaa Massoud, Nada Ali, Assem Kassim, Mostafa AmanAllah, Rokaya Elsayed, Hesham Sheashaa, Yousef Husseiny, Nourhan Hassan, Kirollos Badr, Amr Elkhateb, Verina Fouad, Mayada Elfishawy, Omar Medhat, Mai Mustafa, Noha Khalil, Rawan Elsayed, Youssef Nada, Passant Elshawarbi, Noha Abdelmoneim, Nada Gamal, Mariam Messiha, Marihan Ghazy, Emmy Abdelfatah, Febronia Nasry, Ramy Gayed, Marian Eesa, Merna Luis, Estfana Eskandar, Shenoda Yacoub, Alaa Saud, Maram Rajab, Mariam Abdelaziz, Nadine Elgamal, Hutaf Jaber, Sara Tayssir, Mark Michael, Ahmed Sabry, Joseph Shehata, Rania Abdelaziz, Sherry Rateb, Ahmed El-Maghraby, Yara Mahjoub, Alaa Amr, Amin Mabrouk, Peter Kelada, Shahd Ragab, Basant Eltaher, Rahma Hassan Galal, Omnya Mahmoud Aly, Taquwa Aly, Rana AbdelHaleem, Areeg ElShaarawy, Omnia Mohamed |
| 113 |
[GO] |
2021―Jan―24 |
Could diet and exercise reduce risk of COVID-19 syndemic? |
Walter M Chesnut, Scott MacDonald, Carlos Gustavo Wambier |
| 114 |
[GO] |
2021―Jan―24 |
Antihistamine and cationic amphiphilic drugs, old molecules as new tools against the COVID-19? |
Clara Gitahy Falcao Faria, Luisa Weiner, Julien Petrignet, Coraline Hingray, Ángel Ruiz De Pellon Santamaria, Bruno O. Villoutreix, Philippe Beaune, Marion Leboyer, Hervé Javelot |
| 115 |
[GO] |
2021―Jan―24 |
SARS-CoV-2 associated polyradiculitis and myocarditis may favour Takotsubo syndrome |
Josef Finsterer, Claudia Stöllberger |
| 116 |
[GO] |
2021―Jan―19 |
Daylight is critical to preserve 5-methoxytryptophol levels in suspected and confirmed COVID-19 patients |
Ahmet Özer Şehirli, Serkan Sayıner |
| 117 |
[GO] |
2021―Jan―11 |
Host genomics of COVID-19: Evidence point towards Alpha 1 antitrypsin deficiency as a putative risk factor for higher mortality rate |
Atanu Kumar Dutta, Kalyan Goswami |
| 118 |
[GO] |
2021―Jan―08 |
Scientific hypothesis and rational pharmacological for the use of sacubitril/valsartan in cardiac damage caused by COVID-19 |
Antonio Vitiello, Raffaele La Porta, Francesco Ferrara |
| 119 |
[GO] |
2021―Jan―08 |
Could COVID-19 anosmia and olfactory dysfunction trigger an increased risk of future dementia in patients with ApoE4? |
Ciro Manzo, Jordi Serra-Mestres, Marco Isetta, Alberto Castagna |
| 120 |
[GO] |
2021―Jan―08 |
COVID-19 patients may become predisposed to pulmonary arterial hypertension |
Yuichiro J. Suzuki, Sofia I. Nikolaienko, Nataliia V. Shults, Sergiy G. Gychka |
| 121 |
[GO] |
2021―Jan―08 |
Platelet hyperactivity in COVID-19: Can the tomato extract fruitflow® be used as an antiplatelet regime? |
Niamh O'Kennedy, Asim K. Duttaroy |
| 122 |
[GO] |
2021―Jan―08 |
What sunspots are whispering about covid-19? |
Mariam M. Morchiladze, Tamila K. Silagadze, Zurab K. Silagadze |
| 123 |
[GO] |
2021―Jan―08 |
Polycations and polyanions in SARS-CoV-2 infection |
I. Ginsburg, E. Fibach |
| 124 |
[GO] |
2021―Jan―04 |
Looking beyond pulmonary disease in COVID-19: a lesson from patients with cystic fibrosis |
Sara Manti, Giuseppe Fabio Parisi, Maria Papale, Enza Mulè, Donatella Aloisio, Novella Rotolo, Salvatore Leonardi |
| 125 |
[GO] |
2021―Jan―02 |
COVID-19 and chronic fatigue syndrome: Is the worst yet to come? |
Peter Wostyn |
| 126 |
[GO] |
2020―Dec―31 |
Will the COVID-19 pandemic increase the prevalence of idiopathic scoliosis? |
Ziyang Liu, Wenbo Jiang, Yong Hai, Yufu Liu, Tie Liu |
| 127 |
[GO] |
2020―Dec―31 |
Fecal microbiota transplantation for COVID-19; a potential emerging treatment strategy |
Seyed Aria Nejadghaderi, Ehsan Nazemalhosseini-Mojarad, Hamid Asadzadeh Aghdaei |
| 128 |
[GO] |
2020―Dec―30 |
Acute kidney injury due to COVID-19 and the circadian rhythm |
Merve Mercan, Ahmet Özer Şehirli, Ugochukwu Chukwunyere, Nurettin Abacıoğlu |
| 129 |
[GO] |
2020―Dec―26 |
Impairment in selenocysteine synthesis as a candidate mechanism of inducible coagulopathy in COVID-19 patients |
George D. Vavougios, Konstantinos T. Ntoskas, Triantafyllos K. Doskas |
| 130 |
[GO] |
2020―Dec―24 |
Phenylmethimazole is a candidate drug for the treatment of severe forms of coronavirus disease 2019 (covid-19) as well as other virus-induced “cytokines storm” |
Cesidio Giuliani, Ines Bucci, Giorgio Napolitano |
| 131 |
[GO] |
2020―Dec―23 |
Spa therapy (Balneotherapy) for rehabilitation of survivors of COVID-19 with persistent symptoms |
Sinan Kardeş |
| 132 |
[GO] |
2020―Dec―23 |
COVID-19/takotsubo/spontaneous coronary artery dissection: Lost in the Bermuda triangle |
John E. Madias |
| 133 |
[GO] |
2020―Dec―22 |
The Plausible Mechanisms of Tramadol for Treatment of COVID-19 |
Nahla E El-Ashmawy, Abdel-Halim A. Lashin, Kamal M. Okasha, Amal M. Abo Kamer, Tarek M. Mostafa, Mona El-Aasr, Ahmed E. Goda, Yusuf A. Haggag, Haytham O. Tawfik, Mariam A. Abo-Saif |
| 134 |
[GO] |
2020―Dec―22 |
Reduction in the incidence of infectious diseases during the COVID-19 pandemic: A hypothesis |
Ashkan MohammadSadeghi |
| 135 |
[GO] |
2020―Dec―22 |
Closing the portal to SARS-CoV-2 cellular entry: May open newer avenues… |
Ridhima Sharma, Rohan Magoon, Brajesh Kaushal |
| 136 |
[GO] |
2020―Dec―17 |
COVID-19 patients could be at high risk for dry socket |
Lakshmi Shetty, Shruti Nahar, Trivina Domah, A. Thirumal Raj |
| 137 |
[GO] |
2020―Dec―10 |
Methylene blue in covid-19 |
Giulio Scigliano, Giuseppe Augusto Scigliano |
| 138 |
[GO] |
2020―Dec―10 |
Ethnicity and the relationship between covid-19 and the herpes simplex viruses |
Peter Bond |
| 139 |
[GO] |
2020―Dec―09 |
Downregulation of microRNA-146a in diabetes, obesity and hypertension may contribute to severe COVID-19 |
Jelena Roganović |
| 140 |
[GO] |
2020―Dec―09 |
Statins and PCSK9 inhibitors: What is their role in coronavirus disease 2019? |
Fotios Barkas, Haralampos Milionis, Georgia Anastasiou, Evangelos Liberopoulos |
| 141 |
[GO] |
2020―Dec―09 |
Correlation between takotsubo cardiomyopathy and SARS-CoV-2 infection |
Lukasz Szarpak, Krzysztof Jerzy Filipiak, Aleksandra Gasecka, Michal Pruc, Anna Drozd, Milosz Jaroslaw Jaguszewski |
| 142 |
[GO] |
2020―Dec―04 |
Hypothesis: A Wearable Device May Help COVID-19 Patients Improve Lung Function |
Margaret L. Dow, Stephen R. Dugan |
| 143 |
[GO] |
2020―Nov―29 |
Inhaled Milrinone for sick COVID-19 cohort: a pathophysiology driven hypothesis! |
Rohan Magoon, Jasvinder Kaur Kohli, Ramesh Kashav |
| 144 |
[GO] |
2020―Nov―28 |
Does tetanus vaccination contribute to reduced severity of the COVID-19 infection? |
Christopher D. Rickett, Kristyn J. Maschhoff, Sreenivas R. Sukumar |
| 145 |
[GO] |
2020―Nov―28 |
Androgenetic alopecia may be associated with weaker COVID-19 T-cell immune response: An insight into a potential COVID-19 vaccine booster |
Andy Goren, Flavio Adsuara Cadegiani, Carlos Gustavo Wambier, Sergio Vano-Galvan, Antonella Tosti, Jerry Shapiro, Natasha Atanaskova Mesinkovska, Paulo Müller Ramos, Rodney Sinclair, Omar Lupi, Jana Hercegova, John McCoy |
| 146 |
[GO] |
2020―Nov―28 |
Why does SARS-CoV-2 survive longer on plastic than on paper? |
Denis E. Corpet |
| 147 |
[GO] |
2020―Nov―27 |
Can preprocedural mouthrinses reduce SARS-CoV-2 load in dental aerosols? |
Isabella N R Reis Reis INR, Guilherme Castro Lima Silva do Amaral Amaral GCLS, Aldrin André Huamán Mendoza Mendoza AAH, Yasmin Teixeira das Graças Graças YT, Maria Cássia Mendes-Correa Mendes-Correa MC, Giuseppe Alexandre Romito Romito GA, Claudio Mendes Pannuti Pannuti CM |
| 148 |
[GO] |
2020―Nov―26 |
Can chloroquine/hydroxychloroquine prove efficient in cancer cachexia? A hypothesis in the era of COVID-19 |
Miroslaw Kiedrowski, Przemyslaw Kapala, Marlena Kiedrowska, Anna Skoczyńska, Aleksandra Czerw, Andrzej Deptała |
| 149 |
[GO] |
2020―Nov―25 |
Tackling the COVID-19 “cytokine storm” with microRNA mimics directly targeting the 3’UTR of pro-inflammatory mRNAs |
Jessica Gasparello, Alessia Finotti, Roberto Gambari |
| 150 |
[GO] |
2020―Nov―25 |
COVID-19 changes the lifestyle of the population and subtly reduces the incidence of metabolic disease |
Xianqiang Yu |
| 151 |
[GO] |
2020―Nov―25 |
COVID-19: Does the infectious inoculum dose-response relationship contribute to understanding heterogeneity in disease severity and transmission dynamics? |
Wim Van Damme, Ritwik Dahake, Remco van de Pas, Guido Vanham, Yibeltal Assefa |
| 152 |
[GO] |
2020―Nov―24 |
Combating hypoxemia in COVID-19 patients with a natural oxygen carrier, HEMO2Life® (M101) |
Elise Lupon, Alexandre G. Lellouch, Franck Zal, Curtis L. Cetrulo, Laurent A. Lantieri |
| 153 |
[GO] |
2020―Nov―24 |
Is the oral cavity a reservoir for prolonged SARS-CoV-2 shedding? |
Matthias Troeltzsch, Ronald Berndt, Markus Troeltzsch |
| 154 |
[GO] |
2020―Nov―24 |
Passive Inhaled mRNA Vaccination for SARS-Cov-2: A Proposal |
Wee Song Yeo, Qin Xiang Ng |
| 155 |
[GO] |
2020―Nov―24 |
The firsrt psychiatric pandemic: Encephalitis lethargica, 1917-27 |
Edward Shorter |
| 156 |
[GO] |
2020―Nov―23 |
Alveolar epithelial cell type II could be the main target of SARS-CoV-2 virus and COVID-19 development via NF-Kb pathway deregulation: a physio-pathological theory |
M. Carcaterra, C. Caruso |
| 157 |
[GO] |
2020―Nov―22 |
Facemasks in the COVID-19 era: A health hypothesis |
Baruch Vainshelboim |
| 158 |
[GO] |
2020―Nov―22 |
COVID-19: A double threat to takotsubo cardiomyopathy and spontaneous coronary artery dissection? |
Fahimehalsadat Shojaei, Zahra Habibi, Sogand Goudarzi, Fatemeh Dehghani Firouzabadi, Sahar Memar Montazerin, Homa Najafi, Farima Kahe, Kaveh Momenzadeh, Mahshid Mir, Faris Khan, Umer Jamil, Adeel Jamil, Jane J. Lee, Gerald Chi |
| 159 |
[GO] |
2020―Nov―22 |
Are oral manifestations related to SARS-CoV-2 mediated hemolysis and anemia? |
Gargi S. Sarode, Sachin C. Sarode, Amol R. Gadbail, Shailesh Gondivkar, Nilesh Kumar Sharma, Shankargouda Patil |
| 160 |
[GO] |
2020―Nov―21 |
Could changes in the airborne pollutant particulate matter acting as a viral vector have exerted selective pressure to cause COVID-19 evolution? |
Yves Muscat Baron |
| 161 |
[GO] |
2020―Nov―20 |
More that ACE2? NRP1 may play a central role in the underlying pathophysiological mechanism of olfactory dysfunction in COVID-19 and its association with enhanced survival |
Claire Hopkins, Jerome R. Lechien, Sven Saussez |
| 162 |
[GO] |
2020―Nov―20 |
Zinc supplementation for males during COVID-19: Is it beneficial ? |
Areej Mohamed Ateya, Nagwa A. Sabri |
| 163 |
[GO] |
2020―Nov―17 |
Development of Integrated Microfluidic Platform Coupled with Surface-Enhanced Raman Spectroscopy for Diagnosis of COVID-19 |
Siddhita Amit Jadhav, Pullithadathil. Biji, Manoj Kumar Panthalingal, Chilakapati Murali, Anjali Kulkarni, Sankaranarayanan Rajkumar, Dattatraya S. Joshi, Sundaram Natarajan |
| 164 |
[GO] |
2020―Nov―16 |
Hydrothermotherapy in prevention and treatment of mild to moderate cases of COVID-19 |
Francisco E Ramirez, Alberto Sanchez, Aki T Pirskanen |
| 165 |
[GO] |
2020―Nov―12 |
Hypothesis: alpha-1-antitrypsin is a promising treatment option for COVID-19 |
Xiyuan Bai, Joseph Hippensteel, Alida Leavitt, James P. Maloney, David Beckham, Cindy Garcia, Qing Li, Brian M. Freed, Diane Ordway, Robert A. Sandhaus, Edward D. Chan |
| 166 |
[GO] |
2020―Nov―12 |
SMOKING AND COVID-19, THE PARADOX TO DISCOVER:An Italian retrospective, observational study in hospitalized and non-hospitalized patients |
Carlo Lombardi, Elena Roca, Laura Ventura, Marcello Cottini |
| 167 |
[GO] |
2020―Nov―12 |
COVID-19’s toll on the elderly and those with diabetes mellitus - is vitamin B12 deficiency an accomplice? |
Andrew Kien Han Wee |
| 168 |
[GO] |
2020―Nov―11 |
Is there an underlying link between COVID-19, ACE2, oxytocin and vitamin D? |
Phuoc-Tan Diep |
| 169 |
[GO] |
2020―Nov―09 |
Dendritic Cell Vaccine Immunotherapy; the beginning of the end of Cancer and COVID-19. A Hypothesis |
Mona Kamal Saadeldin, Amal Kamal Abdel-Aziz, Ahmed Abdellatif |
| 170 |
[GO] |
2020―Nov―08 |
Cyclin dependent kinase inhibitors as a new potential therapeutic option in management of COVID-19 |
Mohamed Gargouri, Aboubaker Alzwi, Anis Abobaker |
| 171 |
[GO] |
2020―Nov―08 |
The ‘core’ of the ‘score’(COVID-19)? |
Rohan Magoon |
| 172 |
[GO] |
2020―Nov―08 |
Does yadgir population have copper-mediated intrinsic immunity to resist COVID-19 challenge? |
Shekar Patil, U.S. Vishal Rao, Gururaj Arakeri, Shankaragouda Patil, Peter A. Brennan |
| 173 |
[GO] |
2020―Nov―06 |
Blood clots in COVID-19 patients: Simplifying the curious mystery |
Saurav Biswas, Vikram Thakur, Parneet Kaur, Azhar Khan, Saurabh Kulshrestha, Pradeep Kumar |
| 174 |
[GO] |
2020―Nov―06 |
Could a family history of type 2 diabetes be a risk factor to the endothelial damage in the patient with COVID-19? |
Noé Alvarado-Vasquez |
| 175 |
[GO] |
2020―Nov―06 |
SARS-CoV 2;Possible alternative virus receptors and pathophysiological determinants |
Leo Pruimboom |
| 176 |
[GO] |
2020―Nov―05 |
COVID-19 Inflammation Results in Urine Cytokine Elevation and Causes COVID-19 Associated Cystitis (CAC) |
Laura E. Lamb, Nivedita Dhar, Ryan Timar, Melissa Wills, Sorabh Dhar, Michael B. Chancellor |
| 177 |
[GO] |
2020―Nov―05 |
Inhaled route and anti-inflammatory action of ivermectin: do they hold promise in fighting against COVID-19? |
Niti Mittal, Rakesh Mittal |
| 178 |
[GO] |
2020―Nov―04 |
Should the convergence between the social and biological vulnerabilities of black communities and the COVID-19 pandemic be considered? |
Andrea Maria Narciso Rocha de Paula, Daniel Coelho, Claudia Luz de Oliveira, Ana Paula Venuto Moura |
| 179 |
[GO] |
2020―Nov―01 |
Periodontal pocket and COVID-19: Could there be a possible link? |
Nirupa Elisetti |
| 180 |
[GO] |
2020―Oct―23 |
May Interferon λ be a novel therapeutic approach against COVID-19? |
Azam Roohi, Pejman Soroosh |
| 181 |
[GO] |
2020―Oct―22 |
Therapeutic potential for clomiphene, a selective estrogen receptor modulator, in the treatment of COVID-19 |
Morteza Ghasemnejad-Berenji, Sarvin Pashapour, Hojat Ghasemnejad-Berenji |
| 182 |
[GO] |
2020―Oct―21 |
A Multiple Therapy Hypothesis for Treatment of COVID-19 Patients |
Thomas P. Oscar |
| 183 |
[GO] |
2020―Oct―21 |
Ac2-26 Mimetic Peptide of Annexin A1 to treat severe COVID-19: a hypothesis |
Andre Gustavo Bonavita |
| 184 |
[GO] |
2020―Oct―09 |
The potential use of ABO blood group system for risk stratification of COVID-19 |
Antoine Fakhry AbdelMassih, Reham Mahrous, AbdelFattah Taha, Alaa Saud, Aliaa Osman, Bishoy Kamel, Elaria Yacoub, Esraa Menshawey, Habiba-Allah Ismail, Lina Aita, Maria Dous, Marina Saad, Mariam AbdelAziz, Mario Zaghar, Noura Shebl, Nadine El-Husseiny, Nourhan Fahmy, Nouran Hegazy, Omar Khalid, Osama Saad, Peter Afdal, Rahma Menshawey, Reem Husseiny, Sandra Sherien, Sara Salama, Salma Gad, Sajjad Ali, Sayid Maalim, Sarah Ismail, Yara ElHefnawi, Youstina Aziz, Raghda Fouda |
| 185 |
[GO] |
2020―Oct―08 |
Pro resolving inflammatory effects of the lipid mediators of Omega 3 fatty acids and its implication in SARS COVID-19 |
Pedro-Antonio Regidor, Fernando Gonzalez Santos, Jose Miguel Rizo, Fernando Moreno Egea |
| 186 |
[GO] |
2020―Oct―08 |
NCAM protein and SARS-COV-2 surface proteins: in-silico hypothetical evidence for the immunopathogenesis of Guillain-Barré Syndrome |
Sara Morsy |
| 187 |
[GO] |
2020―Oct―07 |
COMMENT ON AN ARTICLE: ,High dose folic acid is a potential treatment for pulmonary hypertension, including when associated with COVID-19 pneumonia“ |
Omer Ć. Ibrahimagić, Suljo Kunić |
| 188 |
[GO] |
2020―Oct―07 |
Is a COVID-19 vaccine developed by nature already at work? |
Nilesh Kumar Sharma, Sachin C. Sarode, Gargi Sarode, Shankargouda Patil |
| 189 |
[GO] |
2020―Oct―06 |
COVID-19 induced ARDS, and the use of galantamine to activate the cholinergic anti-inflammatory pathway |
Farrukh Ahmad |
| 190 |
[GO] |
2020―Oct―06 |
Dysimmunity and inflammatory storm: Watch out for bone lesions in COVID-19 infection |
Huaqiang Tao, Gaoran Ge, Wenming Li, Xiaolong Liang, Hongzhi Wang, Ning Li, Houyi Sun, Wei Zhang, Dechun Geng |
| 191 |
[GO] |
2020―Oct―05 |
A possible application of hinokitiol as a natural zinc ionophore and anti-infective agent for the prevention and treatment of COVID-19 and viral infections |
Ba X. Hoang, Bo Han |
| 192 |
[GO] |
2020―Oct―01 |
Hypothesis: Oxytocin Is A Direct COVID-19 Antiviral |
Phuoc-Tan Diep, Khojasta Talash, Violet Kasabri |
| 193 |
[GO] |
2020―Oct―01 |
Falls in older adults: the new pandemic in the post COVID-19 era? |
Miguel Ángel De La Cámara |
| 194 |
[GO] |
2020―Oct―01 |
Viral replication of SARS-CoV-2 could be self-limitative - the role of the renin-angiotensin system on COVID-19 pathophysiology |
Vinicius Novaes Rocha |
| 195 |
[GO] |
2020―Sep―30 |
SARS-CoV-2 cell entry receptor ACE2 mediated endothelial dysfunction leads to vascular thrombosis in COVID-19 patients |
Ashutosh Kumar, Ravi K. Narayan, Chiman Kumari, Muneeb A. Faiq, Maheswari Kulandhasamy, Kamla Kant, Vikas Pareek |
| 196 |
[GO] |
2020―Sep―29 |
COVID-19, Myocardial Edema and Dexamethasone |
Moezedin Javad Rafiee, Faranak Babaki Fard, Matthias G. Friedrich |
| 197 |
[GO] |
2020―Sep―28 |
COVID-19 in children: could pertussis vaccine play the protective role? |
Mohamad Bachar Ismail, Sarah Al Omari, Rayane Rafei, Fouad Dabboussi, Monzer Hamze |
| 198 |
[GO] |
2020―Sep―28 |
Chronic Exposure to Air Pollution Implications on COVID-19 Severity |
Sarah A. Deek |
| 199 |
[GO] |
2020―Sep―25 |
The “COVID-19 Score” can predict the need for tracheal intubation in critically ill COVID-19 patients - A hypothesis |
Ankur Khandelwal, Gyaninder Pal Singh, Girija Prasad Rath, Arvind Chaturvedi |
| 200 |
[GO] |
2020―Sep―24 |
Factors related to asymptomatic or severe COVID-19 infection |
Eduardo Pérez-Campos Mayoral, María Teresa Hernández-Huerta, Laura Pérez-Campos Mayoral, Carlos Alberto Matias-Cervantes, Gabriel Mayoral-Andrade, Luis Ángel Laguna Barrios, Eduardo Pérez-Campos |
| 201 |
[GO] |
2020―Sep―24 |
Potential Role of GcMAF in suppressing the severity of COVID-19-induced immune responses: lesson learned from HIV |
Lucrezia Spadera, Maria Spadera |
| 202 |
[GO] |
2020―Sep―19 |
Should an intersection between visceral leishmaniasis endemicity and the COVID-19 pandemic be considered? |
Sílvio Fernando Guimarães Carvalho, Thallyta Maria Vieira, Ana Paula Venuto Moura, Marileia Chaves Andrade |
| 203 |
[GO] |
2020―Sep―19 |
Aerosol anguish in dentistry in COVID-19 pandemic: A hypotheses or reality? |
Harneet Kaur, Anuraj Singh Kochhar |
| 204 |
[GO] |
2020―Sep―18 |
The paradoxical effect of IL-6 and implications for the use of Tocilizumab in Covid-19 patients |
Vincenzo Bruzzese, Antonio Ivan Lazzarino |
| 205 |
[GO] |
2020―Sep―17 |
Smart polymeric eye gear: A possible preventive measure against ocular transmission of COVID-19 |
Dipak Kumar Sahu, Deepak Pradhan, Pradeep Kumar Naik, Biswakanth Kar, Goutam Ghosh, Goutam Rath |
| 206 |
[GO] |
2020―Sep―17 |
Fabry disease patients have an increased risk of stroke in the COVID-19 ERA. A hypothesis |
R.C. Reisin, P. Rozenfeld, P. Bonardo |
| 207 |
[GO] |
2020―Sep―17 |
Do not call it COVID-19, it might have been the second wave |
Frank Rühli, Patrick Eppenberger, Maciej Henneberg |
| 208 |
[GO] |
2020―Sep―17 |
Role of testosterone in COVID-19 patients - A double-edged sword? |
Aneela N. Hussain, Fazal Hussain, Shahrukh K. Hashmi |
| 209 |
[GO] |
2020―Sep―17 |
Obesity, abdominal organ size and COVID-19 severity |
Lina Zabuliene, Ioannis Ilias |
| 210 |
[GO] |
2020―Sep―17 |
Host - virus - drug interactions as determinants of COVID-19’s phenotypes: A data-driven hypothesis |
George D. Vavougios |
| 211 |
[GO] |
2020―Sep―16 |
Impairment of the cholinergic anti-inflammatory pathway in older subjects with severe COVID-19 |
Nunzio Pomara, Bruno P. Imbimbo |
| 212 |
[GO] |
2020―Sep―16 |
Periodontal disease and targeted prevention using aMMP-8 point-of-care oral fluid analytics in the COVID-19 era |
Ismo T. Räisänen, Kehinde A. Umeizudike, Pirjo Pärnänen, Pia Heikkilä, Taina Tervahartiala, Solomon O. Nwhator, Andreas Grigoriadis, Dimitra Sakellari, Timo Sorsa |
| 213 |
[GO] |
2020―Sep―16 |
Alcohol consumption and obesity: The hidden scare with COVID-19 severity |
Bushra Bilal, Faizan Saleem, Syeda Sadia Fatima |
| 214 |
[GO] |
2020―Sep―16 |
Phosphatidylglycerol and surfactant: A potential treatment for COVID-19? |
Wendy B. Bollag, Joyce N. Gonzales |
| 215 |
[GO] |
2020―Sep―16 |
A hypothesis for examining dihydroxyacetone, the active component in sunless tanning products, as a topical prophylactic against SARS-COV-2 transmission |
David M. Perrin |
| 216 |
[GO] |
2020―Sep―13 |
Is there an under-representation of skin of colour images during the COVID-19 outbreak? |
Nicolas Kluger, Mahtab Samimi |
| 217 |
[GO] |
2020―Sep―13 |
Relevance of SARS-CoV-2 related factors ACE2 and TMPRSS2 expressions in gastrointestinal tissue with pathogenesis of digestive symptoms, diabetes-associated mortality, and disease recurrence in COVID-19 patients |
Ashutosh Kumar, Muneeb A. Faiq, Vikas Pareek, Khursheed Raza, Ravi K. Narayan, Pranav Prasoon, Pavan Kumar, Maheswari Kulandhasamy, Chiman Kumari, Kamla Kant, Himanshu N. Singh, Rizwana Qadri, Sada N. Pandey, Santosh Kumar |
| 218 |
[GO] |
2020―Sep―12 |
Empiric Antibiotics in Management of Inpatient Pregnant Women Infected with Coronavirus Disease 2019 (COVID-19): Focusing on Inflammation and Preterm Labor |
Amir Hossein Norooznezhad, Sedigheh Hantoushzadeh, Alireza A. Shamshirsaz |
| 219 |
[GO] |
2020―Sep―11 |
Considerations on the article De Bernardis, E., & Busà, L. (2020). A putative role for the tobacco mosaic virus in smokers’ resistance to COVID-19 Medical Hypotheses, 110153 |
Vincenzo Zagà, Daniel L. Amram, Giacomo Mangiaracina, Maria Sofia Cattaruzza |
| 220 |
[GO] |
2020―Sep―11 |
The viral protein fragment theory of COVID-19 pathogenesis |
Yuichiro J. Suzuki |
| 221 |
[GO] |
2020―Sep―10 |
Potential of electric stimulation for the management of COVID-19 |
Prince Allawadhi, Amit Khurana, Sachin Allwadhi, Uma Shanker Navik, Kamaldeep Joshi, Anil Kumar Banothu, Kala Kumar Bharani |
| 222 |
[GO] |
2020―Sep―10 |
Advanced drug delivery systems can assist in targeting coronavirus disease (COVID-19): A hypothesis |
Meenu Mehta, Parteek Prasher, Mousmee Sharma, Madhur D Shastri, Navneet Khurana, Manish Vyas, Harish Dureja, Gaurav Gupta, Krishnan Anand, Saurabh Satija, Dinesh Kumar Chellappan, Kamal Dua |
| 223 |
[GO] |
2020―Sep―10 |
Washing Hands and the Face May Reduce COVID-19 Infection |
Andrzej Przekwas, Zhijian Chen |
| 224 |
[GO] |
2020―Sep―10 |
COVID-19: Endogenous Retinoic Acid Theory and Retinoic Acid Depletion Syndrome |
Aziz Rodan Sarohan |
| 225 |
[GO] |
2020―Sep―09 |
Distinguishing between Typical Kawasaki Disease and Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2 |
Wee-Song Yeo, Qin Xiang Ng |
| 226 |
[GO] |
2020―Sep―09 |
Role of inositol to improve surfactant functions and reduce IL-6 levels: a potential adjuvant strategy for SARS-CoV-2 pneumonia? |
Antonio Simone Laganà, Vittorio Unfer, Simone Garzon, Mariano Bizzarri |
| 227 |
[GO] |
2020―Sep―04 |
Defensin 5 for prevention of SARS-CoV-2 invasion and Covid-19 Disease |
Yaron Niv |
| 228 |
[GO] |
2020―Sep―04 |
SARS-CoV-2 and miRNA-like inhibition power |
Jacques Demongeot, Hervé Seligmann |
| 229 |
[GO] |
2020―Sep―03 |
Heme oxygenase-1 (HO-1) cytoprotective pathway: A potential treatment strategy against coronavirus disease 2019 (COVID-19)-induced cytokine storm syndrome |
Maxime Rossi, Michael Piagnerelli, Alain Van Meerhaeghe, Karim Zouaoui Boudjeltia |
| 230 |
[GO] |
2020―Sep―03 |
COVID-19 and the renin-angiotensin system (RAS): a spark that sets the forest alight? |
O.J. Wiese, B.W. Allwood, A.E. Zemlin |
| 231 |
[GO] |
2020―Sep―03 |
Can roflumilast become steroid-sparing alternative in the treatment of COVID-19? |
Chirag A Shah |
| 232 |
[GO] |
2020―Sep―03 |
A role of glycation and methylation for SARS-CoV-2 infection in diabetes? |
Giovanni Sartore, Eugenio Ragazzi, Luca Faccin, Annunziata Lapolla |
| 233 |
[GO] |
2020―Sep―02 |
Hypotheses about sub-optimal hydration in the weeks before coronavirus disease (COVID-19) as a risk factor for dying from COVID-19 |
Jodi D. Stookey, Prasanna K.R. Allu, Dorothee Chabas, David Pearce, Florian Lang |
| 234 |
[GO] |
2020―Sep―02 |
Hypothesis: Nasal vs. oral inhalation accounts for the severity of COVID-19 |
Barry R. Komisaruk |
| 235 |
[GO] |
2020―Sep―02 |
Life-threatening course in coronavirus disease 2019 (COVID-19): Is there a link to methylenetetrahydrofolic acid reductase (MTHFR) polymorphism and hyperhomocysteinemia? |
Matthias Karst, Josef Hollenhorst, Johannes Achenbach |
| 236 |
[GO] |
2020―Sep―02 |
Ketonuria with or without ketoacidosis as the presenting manifestation of SARS-CoV-2 (COVID-19) among uncontrolled Type 2 Diabetic patients |
Mohamed H Emara, Usama Mazid, Mohamed Ali Atta, Sahar Elshahat, Aya Mohamed Mahros |
| 237 |
[GO] |
2020―Sep―02 |
Second wave of Covid-19 is determined by immune mechanism |
Osama Hussein |
| 238 |
[GO] |
2020―Sep―02 |
McGurk effect and audiovisual speech perception in students with learning disabilities exposed to online teaching during the COVID-19 pandemic |
Elena Kkese |
| 239 |
[GO] |
2020―Sep―02 |
Olfactory dysfunction may predict myocardial injury in COVID-19 patients |
Ercan Akşit, Özge Çağlar Çil, Hakkı Kaya |
| 240 |
[GO] |
2020―Sep―02 |
Non-Invasive Assessment of Endothelial Dysfunction: A novel method to predict severe COVID-19? |
Sarangini Yoganandamoorthy, M.A.D.S.N. Munasinghe, L.V.U. Wanigasuriya, M.K.K. Priyankara, Saroj Jayasinghe |
| 241 |
[GO] |
2020―Sep―02 |
Premises among SARS-CoV-2, dysbiosis and diarrhea: Walking through the ACE2/mTOR/autophagy route |
Ana Patrícia de Oliveira, André Luis Fernandes Lopes, Gabriella Pacheco, Isabela Ribeiro de Sá Guimarães Nolêto, Lucas Antonio Duarte Nicolau, Jand Venes Rolim Medeiros |
| 242 |
[GO] |
2020―Sep―02 |
Red blood cell exchange for SARS-CoV-2: A Gemini of therapeutic opportunities |
Sean M. Hacking |
| 243 |
[GO] |
2020―Aug―30 |
Can Hyperbaric Oxygen safely serve as an anti-inflammatory treatment for COVID-19? |
Anders Kjellberg, Antonio De Maio, Peter Lindholm |
| 244 |
[GO] |
2020―Aug―27 |
COVID-19 and ethnicity: does reduced responsiveness to glucocorticoids explain the more aggressive nature of disease among minorities? |
Abhinav Karan, Kabeer Ali, Kirin Rambaran, Pedro Del Corral, Sateesh Sakhamuri, Surujpal Teelucksingh |
| 245 |
[GO] |
2020―Aug―26 |
Role of Latent Tuberculosis Infections in Reduced COVID-19 Mortality: Evidence from an Instrumental Variable Method Analysis |
Harutaka Takahashi |
| 246 |
[GO] |
2020―Aug―26 |
SARS-CoV-2 dysregulation of PTBP1 and YWHAE/Z gene expression: a primer of neurodegeneration |
George D. Vavougios |
| 247 |
[GO] |
2020―Aug―26 |
SARS-CoV-2-mediated encephalitis: role of AT2R receptors in the blood-brain barrier |
Antônio Kleiton de Sousa, Diva de Aguiar Magalhães, Jayro dos Santos Ferreira, André Luiz dos Reis Barbosa |
| 248 |
[GO] |
2020―Aug―25 |
Vitamin K epoxide reductase complex subunit 1 (VKORC1) gene polymorphism as determinant of differences in Covid-19-related disease severity |
Rob Janssen, Jona Walk |
| 249 |
[GO] |
2020―Aug―24 |
Nasal lavage containing Angiotensin- Converting Enzyme -2 agonist can prevent and reduce viral load in COVID-19 |
Gaelle Vofo, Ronit Brodie, Menachem Gross |
| 250 |
[GO] |
2020―Aug―24 |
Repurposing Prolactin as a Promising Immunomodulator for the Treatment of COVID-19: Are Common Antiemetics the Wonder Drug to Fight Coronavirus? |
Amarnath Sen |
| 251 |
[GO] |
2020―Aug―24 |
COVID-19: Can the symptomatic SARS-CoV-2 infection affect the homeostasis of the gut-brain-microbiota axis? |
Marileia Chaves Andrade, Rodolfo Souza de Faria, Sergio Avelino Mota Nobre |
| 252 |
[GO] |
2020―Aug―19 |
A new approach for COVID-19 treatment by micro-RNA |
Sobhy Hassab El-Nabi, Mohamed Elhiti, Mostafa El-Sheekh |
| 253 |
[GO] |
2020―Aug―18 |
Could Imiquimod (5% Aldara) or Other TLR7 Agonists be Used in The Treatment of COVID-19? |
Huseyin Avcilar, Ahmet Eken |
| 254 |
[GO] |
2020―Aug―17 |
It is Time To Drop Hydroxychloroquine From our COVID-19 Armamentarium |
Tarek Kashour, Imad M. Tleyjeh |
| 255 |
[GO] |
2020―Aug―17 |
Household representative sample strategy for COVID-19 large-scale population screening |
John Takyi-Williams |
| 256 |
[GO] |
2020―Aug―17 |
Exercise as medicine for COVID-19: on PPAR with emerging pharmacotherapy |
Kevin S. Heffernan, Sushant Ranadive, Sae Young Jae |
| 257 |
[GO] |
2020―Aug―15 |
The AI-discovered Aetiology of COVID-19 and Rationale of the Irinotecan+ Etoposide Combination Therapy for Criti- cally Ill COVID-19 Patients |
Bragi Lovetrue |
| 258 |
[GO] |
2020―Aug―14 |
Alpha-lipoic acid may protect patients with diabetes against COVID-19 infection |
Erkan Cure, Medine Cumhur Cure |
| 259 |
[GO] |
2020―Aug―14 |
A potential therapeutic combination for treatment of COVID-19: synergistic effect of DPP4 and RAAS suppression |
Phyu Phyu Khin, Seon-Heui Cha, Hee-Sook Jun, Jong Han Lee |
| 260 |
[GO] |
2020―Aug―10 |
Bone biology and COVID-19 infection: Is ACE2 a potential influence factor? |
Huaqiang Tao, Jiaxiang Bai, Weicheng Zhang, Kai Zheng, Pengfei Guan, Gaoran Ge, Meng Li, Dechun Geng |
| 261 |
[GO] |
2020―Aug―10 |
SCan Charcoal Improve Outcomes in COVID-19 Infections? |
Zeid J. Khitan, Imran Khawaja, Maurice A. Mufson, Juan R. Sanabria, Nader G. Abraham, Stephen J. Peterson, Uma Sundaram, Joseph I. Shapiro |
| 262 |
[GO] |
2020―Aug―10 |
Infection-iron interaction during COVID-19 pandemic: time to re-design iron supplementation programs |
Little Flower Augustine, Vydehi Mullapudi, Sadhana Subramanyan, Bharati Kulkarni |
| 263 |
[GO] |
2020―Aug―07 |
IL-17A and TNF-α as potential biomarkers for acute respiratory distress syndrome and mortality in patients with obesity and COVID-19 |
José J. Leija-Martínez, Fengyang Huang, Blanca E. Del-Río-Navarro, Fausto Sanchéz-Muñoz, Onofre Muñoz-Hernández, Abraham Giacoman-Martínez, Margareth S. Hall-Mondragon, Dario Espinosa-Velazquez |
| 264 |
[GO] |
2020―Aug―07 |
Common determinants of severe Covid-19 infection are explicable by SARS-CoV-2 secreted glycoprotein interaction with the CD33-related Siglecs, Siglec-3 and Siglec-5/14 |
Simon H Murch |
| 265 |
[GO] |
2020―Aug―07 |
Is there a role for insulin-like growth factor inhibition in the treatment of COVID-19-related adult respiratory distress syndrome? |
Bryan J. Winn |
| 266 |
[GO] |
2020―Aug―05 |
Mitochondrial-targeted ubiquinone: A potential treatment for COVID-19 |
Lichen Ouyang, Jie Gong |
| 267 |
[GO] |
2020―Aug―05 |
Apparent difference in fatalities between Central Europe and East Asia due to SARS-COV-2 and COVID-19: Four hypotheses for possible explanation |
Naoki Yamamoto, Georg Bauer |
| 268 |
[GO] |
2020―Aug―05 |
SARS-CoV-2 infection and impact on female genital tract: An untested hypothesis |
Eleftherios Vavoulidis, Chrysoula Margioula-Siarkou, Stamatios Petousis, Konstantinos Dinas |
| 269 |
[GO] |
2020―Aug―05 |
Air conditioning system usage and SARS-CoV-2 Transmission dynamics in Iran |
Mahmoud Reza Pourkarim, Marijn Thijssen, Philippe Lemey, Anne-Mieke Vandamme, Marc Van Ranst |
| 270 |
[GO] |
2020―Aug―02 |
The influence of ABO blood groups on COVID-19 susceptibility and severity: a molecular hypothesis based on carbohydrate-carbohydrate interactions |
José Caetano Silva-Filho, Cynthia Germoglio Farias de Melo, Janaína Lima de Oliveira |
| 271 |
[GO] |
2020―Jul―31 |
A putative role for the tobacco mosaic virus in smokers’ resistance to COVID-19 |
E. de Bernardis, L. Busà |
| 272 |
[GO] |
2020―Jul―31 |
Ankaferd hemostat (ABS) as a potential mucosal topical agent for the management of COVID-19 syndrome based on its PAR-1 inhibitory effect and oestrogen content |
Fatma Beyazit, Yavuz Beyazit, Alpaslan Tanoglu, Ibrahim C. Haznedaroglu |
| 273 |
[GO] |
2020―Jul―31 |
The importance of cell-mediated immunity in COVID-19-An opinion |
Henna Iqbal |
| 274 |
[GO] |
2020―Jul―31 |
Why do children seem to be more protected against COVID-19? A hypothesis |
Bruno Sposato, Marco Scalese |
| 275 |
[GO] |
2020―Jul―30 |
Estrogen shields women from COVID-19 complications by reducing ER stress |
Sana Shabbir, Assad Hafeez, Muhammad Arshad Rafiq, Muhammad Jawad Khan |
| 276 |
[GO] |
2020―Jul―29 |
Are night shift workers at an increased risk for COVID-19? |
Rachel K. Lim, Carlos G. Wambier, Andy Goren |
| 277 |
[GO] |
2020―Jul―26 |
Environmental pollutant exposure can exacerbate COVID-19 neurologic symptoms |
Michael Sigfrid S. Reyes, Paul Mark B. Medina |
| 278 |
[GO] |
2020―Jul―26 |
High dose folic acid is a potential treatment for Pulmonary Hypertension, including when associated with COVID-19 pneumonia |
Esko Wiltshire, Alexia Sophie Peña, Karen MacKenzie, Geoffrey Shaw, Jennifer Couper |
| 279 |
[GO] |
2020―Jul―26 |
The Possible Immunoregulatory and Anti-Inflammatory Effects of Selective Serotonin Reuptake Inhibitors in Coronavirus Disease Patients |
Mohammed Gaber Mohamed Hamed, Radwa Samir Hagag |
| 280 |
[GO] |
2020―Jul―25 |
Autoimmunity to ACE2 as a possible cause of tissue inflammation in Covid-19 |
Alain Townsend |
| 281 |
[GO] |
2020―Jul―25 |
Ventilator-associated pneumonia (VAP) caused by carbapenem-resistant Acinetobacter baumannii in patients with COVID-19: Two problems, one solution? |
William Gustavo Lima, Júlio César Moreira de Brito, Waleska Stephanie da Cruz Nizer |
| 282 |
[GO] |
2020―Jul―24 |
N-acetycysteine: a potential therapeutic agent in COVID-19 infection |
N Jaiswal, M Bhatnagar, H Shah |
| 283 |
[GO] |
2020―Jul―22 |
Low Incidence and Mortality from SARS-CoV-2 in Southern Europe. Proposal of a hypothesis for Arthropod borne Herd immunity |
Martin Balzan |
| 284 |
[GO] |
2020―Jul―22 |
The war against the SARS-CoV2 infection: is it better to fight or mitigate it? |
Fabrizio Dal Moro, Igor Vendramin, Ugolino Livi |
| 285 |
[GO] |
2020―Jul―21 |
Possible Mechanisms Responsible for Acute Coronary Events in COVID-19 |
Aakash R Sheth, Udhayvir S Grewal, Harsh P Patel, Samarthkumar Thakkar, Subhash Garikipati, Jashwanth Gaddam, Danish Bawa |
| 286 |
[GO] |
2020―Jul―21 |
Fenofibrate increases the amount of sulfatide which seems beneficial against Covid-19 |
Karsten Buschard |
| 287 |
[GO] |
2020―Jul―21 |
Prostaglandin D2 as a mediator of lymphopenia and a therapeutic target in COVID-19 disease |
Ajay Gupta, Kate Chander Chiang |
| 288 |
[GO] |
2020―Jul―21 |
‘The Double-Edged Sword’ - An Hypothesis For Covid-19-Induced Salivary Biomarkers |
John Adeoye, Peter Thomson |
| 289 |
[GO] |
2020―Jul―21 |
Acute Respiratory Distress Syndrome from Covid-19: a perfect storm from free radicals? Proposal for a new treatment |
Giulio Scigliano, Giuseppe Augusto Scigliano |
| 290 |
[GO] |
2020―Jul―21 |
Mevalonate pathway, selenoproteins, redox balance, immune system, Covid-19: reasoning about connections |
Giampaolo Minetti |
| 291 |
[GO] |
2020―Jul―18 |
Kawasaki-like disease in children with COVID-19: A hypothesis |
Hamideh Amirfakhryan |
| 292 |
[GO] |
2020―Jul―18 |
Prior infection with intestinal coronaviruses moderates symptom severity and mortality in patients with COVID-19: A hypothesis and preliminary evidence |
Ravi Philip Rajkumar |
| 293 |
[GO] |
2020―Jul―18 |
Can neuromodulation support the fight against the COVID19 pandemic? Transcutaneous non-invasive vagal nerve stimulation as a potential targeted treatment of fulminant acute respiratory distress syndrome |
Gregor A. Bara, Dirk de Ridder, Jaroslaw Maciaczyk |
| 294 |
[GO] |
2020―Jul―16 |
Spironolactone may provide protection from SARS-CoV-2: Targeting androgens, angiotensin converting enzyme 2 (ACE2), and renin-angiotensin-aldosterone system (RAAS) |
Flavio A. Cadegiani, Andy Goren, Carlos G. Wambier |
| 295 |
[GO] |
2020―Jul―15 |
Inhaled Hydroxychloroquine to Improve Efficacy and Reduce Harm in the Treatment of COVID-19 |
Oisín Kavanagh, Anne Marie Healy, Francis Dayton, Shane Robinson, Niall J. O'Reilly, Brian Mahoney, Aisling Arthur, Gavin Walker, John P. Farragher |
| 296 |
[GO] |
2020―Jul―15 |
Inflammation: A bridge between Diabetes and COVID-19, and possible management with sitagliptin |
Negin Mozafari, Soha Azadi, Sanaz Mehdi-Alamdarlou, Hajar Ashrafi, Amir Azadi |
| 297 |
[GO] |
2020―Jul―15 |
COMMENT ON AN ARTICLE: “Homocysteine as a potential predictor of cardiovascular risk in patients with COVID-19“ |
Omer Ć. Ibrahimagić, Dževdet Smajlović, Zikrija Dostović, Mirjana Vidović, Emir Tupković, Suljo Kunić |
| 298 |
[GO] |
2020―Jul―15 |
BCG vaccination and COVID-19: Much ado about nothing? |
M. Caminati, F. Furci, G. Senna, G. Delfino, A. Poli, C. Bovo, V. Patella |
| 299 |
[GO] |
2020―Jul―14 |
Recombinant Protein Targeting and Opsonizing Spike Glycoprotein for Enhancing SARS-CoV-2 Phagocytosis |
Latifa Khattabi |
| 300 |
[GO] |
2020―Jul―13 |
The immunomodulatory effects of exercise against COVID-19 |
Roberto Codella |
| 301 |
[GO] |
2020―Jul―13 |
SARS-CoV-2 infection pathogenesis is related to oxidative stress as a response to aggression |
Rubens Cecchini, Alessandra Lourenço Cecchini |
| 302 |
[GO] |
2020―Jul―12 |
Platelets to surrogate lung inflammation in COVID-19 Patients |
Haripriya Kuchi Bhotla, Tanushri Kaulb, Balamuralikrishnan Balasubramanian, Murugesh Easwaran, Vijaya Anand Arumugam, Manikantan Pappusamy, Muthupandian Saravanan, Arun Meyyazhagan |
| 303 |
[GO] |
2020―Jul―12 |
Eicosapentaenoic free fatty acid to treat patients with SARS-Cov2 infection |
Andrea Belluzzi, Eleonora Scaioli, Luigi Ricciardiello, Giovanni Marasco, Carlotta Belluzzi |
| 304 |
[GO] |
2020―Jul―10 |
The hypothesis that SARS-CoV-2 affects male reproductive ability by regulating autophagy |
Sun Jun |
| 305 |
[GO] |
2020―Jul―09 |
The «moonlighting protein» able to explain the Th1 immune lockdown in severe COVID-19 |
Luca Roncati, Beatrice Lusenti |
| 306 |
[GO] |
2020―Jul―09 |
Does COVID-19 cause permanent damage to olfactory and gustatory function? |
Gamba Paolo |
| 307 |
[GO] |
2020―Jul―09 |
COVID-19 infection can cause chemotherapy resistance development in patients with breast cancer and tamoxifen may cause susceptibility to COVID-19 infection |
Hulya Vatansev, Cengiz Kadiyoran, Medine Cumhur Cure, Erkan Cure |
| 308 |
[GO] |
2020―Jul―09 |
EMMPRIN/BASIGIN as a biological modulator of oral cancer and COVID-19 interaction: novel propositions |
Saranya Varadarajan, Thodur Madapusi Balaji, Sachin C. Sarode, Gargi S. Sarode, Nilesh K. Sharma, Shailesh Gondivkar, Amol Gadbail, Shankargouda Patil |
| 309 |
[GO] |
2020―Jul―09 |
Prospective vaccination of COVID-19 using shRNA-plasmid-LDH nanoconjugate |
Rituparna Acharya |
| 310 |
[GO] |
2020―Jul―08 |
Immuno-pathogenesis of nCOVID-19 and a possible host-directed therapy including anti-inflammatory and anti-viral prostaglandin (PG J2) for effective treatment and reduce the death toll |
Shakeel Shazad, Mark Willcox |
| 311 |
[GO] |
2020―Jul―07 |
Ibuprofen, a traditional drug that may impact the course of COVID-19 new effective formulation in nebulizable solution |
Néstor H. García, Daniela J. Porta, Roxana V. Alasino, Sonia E. Muñoz, Dante M. Beltramo |
| 312 |
[GO] |
2020―Jul―07 |
The Mortality and Psychological Burden Caused by Response to COVID-19 Outbreak: a Hypothesis and a Crude Estimation |
Erlangga Yusuf, Anna Tisler |
| 313 |
[GO] |
2020―Jul―07 |
Surfactant-based prophylaxis and therapy against COVID-19: A possibility |
K. Pramod, Sabna Kotta, U.S. Jijith, A. Aravind, M. Abu Tahir, C.S. Manju, H.V. Gangadharappa |
| 314 |
[GO] |
2020―Jul―03 |
Transpulmonary Electrotherapy for Reduction of Lung Viral Load of SARS-CoV-2 in Patients with COVID-19 |
Nickolas Kipshidze, Valeri S. Chekanov, Nodar Kipshidze, Vivek Reddy, George Dangas |
| 315 |
[GO] |
2020―Jul―03 |
Is the presence of lung injury in COVID-19 an independent risk factor for secondary lung cancer? |
Shao-Lin Tao, Xue-mei Wang, Yong-geng Feng, Po-ming Kang, Qing-yuan Li, Tian-yu Sun, Qun-you Tan, Bo Deng |
| 316 |
[GO] |
2020―Jul―03 |
Is Macrophages Heterogeneity Important in Determining Covid-19 Lethality? |
Pasquale Pagliaro |
| 317 |
[GO] |
2020―Jul―03 |
“COVID-19-related Complications and Decompression Illness Share Main Features. Could the SARS-CoV2-related complications rely on blood foaming ?” |
Pierre DENIS |
| 318 |
[GO] |
2020―Jul―02 |
Epithelial cilia is the first line of defence against Coronavirus; addressing the observed age-gradient in the COVID-19 infection |
Lise Lund Håheim |
| 319 |
[GO] |
2020―Jul―02 |
Factors involved in low susceptibility to COVID-19: An adaptation of high altitude inhabitants |
Celia Choquenaira-Quispe, Vanessa Saldaña-Bobadilla, J. Kenedy Ramirez |
| 320 |
[GO] |
2020―Jul―02 |
Harnessing Adenosine A2A Receptors as a Strategy for Suppressing the Lung Inflammation and Thrombotic Complications of COVID-19: Potential of Pentoxifylline and Dipyridamole |
James J. DiNicolantonio, Jorge Barroso-Aranda |
| 321 |
[GO] |
2020―Jul―01 |
A hypothesis on the role of the human immune system in covid-19 |
Hind Khairi Khashkhosha, Muhammed Elhadi |
| 322 |
[GO] |
2020―Jul―01 |
Have the symptoms of patients with COVID-19 changed over time during hospitalization? |
Fatemeh Dehghani Firouzabadi, Mohammad Dehghani Firouzabadi, Babak Ghalehbaghi, Hesam Jahandideh, Maryam Roomiani, Sogand Goudarzi |
| 323 |
[GO] |
2020―Jul―01 |
SARS-CoV-2 infection in a psoriatic arthritis patient treated with IL-17 inhibitor |
Rosario Foti, Giorgio Amato, Visalli Elisa |
| 324 |
[GO] |
2020―Jun―30 |
Cross-immunity between respiratory coronaviruses may limit COVID-19 fatalities |
Ahmed Yaqinuddin |
| 325 |
[GO] |
2020―Jun―29 |
COVID-19: NAD+ deficiency may predispose the aged, obese and type2 diabetics to mortality through its effect on SIRT1 activity |
R. Miller, A.R. Wentzel, G. Richards |
| 326 |
[GO] |
2020―Jun―28 |
Reposition of Montelukast either alone or in combination with Levocetirizine against SARS-CoV-2 |
Dipankar Bhattacharyya |
| 327 |
[GO] |
2020―Jun―27 |
Rethinking interleukin-6 blockade for treatment of COVID-19 |
S. Scherger, A. Henao Martinez, C. Franco-Paredes, L. Shapiro |
| 328 |
[GO] |
2020―Jun―27 |
Into the looking glass: Post-viral syndrome post COVID-19 |
Ray Perrin, Lisa Riste, Mark Hann, Andreas Walther, Annice Mukherjee, Adrian Heald |
| 329 |
[GO] |
2020―Jun―27 |
Can volcanic trace elements facilitate Covid-19 diffusion? A hypothesis stemming from the Mount Etna area, Sicily |
Loredana Raciti, Rocco Salvatore Calabrò |
| 330 |
[GO] |
2020―Jun―27 |
Biofabrication: An interesting tool to create in vitro model for COVID-19 drug targets |
Anurag Kumar Singh, Gaurav Mishra, Anand Maurya, Giriraj T. Kulkarni, Rajendra Awasthi |
| 331 |
[GO] |
2020―Jun―27 |
Doxycycline or minocycline may be a viable treatment option against SARS-CoV-2 |
Edoardo Francini, Salvatora T. Miano, Anna I. Fiaschi, Guido Francini |
| 332 |
[GO] |
2020―Jun―26 |
Why the lower reported prevalence of asthma in patients diagnosed with COVID-19 validates repurposing EDTA solutions to prevent and manage treat COVID-19 disease |
Daniel P. Cashman |
| 333 |
[GO] |
2020―Jun―26 |
Cytochrome P450-mediated drug interactions in COVID-19 patients: current findings and possible mechanisms |
Mahmoud A. El-Ghiaty, Sherif M. Shoieb, Ayman O.S. El-Kadi |
| 334 |
[GO] |
2020―Jun―25 |
Will an obesity pandemic replace the coronavirus disease-2019 (COVID-19) pandemic? |
Abdelaziz Ghanemi, Mayumi Yoshioka, Jonny St-Amand |
| 335 |
[GO] |
2020―Jun―25 |
Coronavirus disease 2019 (COVID 19) and Malaria. Have anti glycoprotein antibodies a role? |
Aurora Parodi, Emanuele Cozzani |
| 336 |
[GO] |
2020―Jun―25 |
SARS-CoV-2 and the sympathetic immune response: dampening inflammation with antihypertensive drugs (Clonidine and Propranolol) |
Sanjiv K Hyoju, Olga Zaborina, Harry van Goor |
| 337 |
[GO] |
2020―Jun―24 |
rAre graphene and graphene-derived products capable of preventing COVID-19 infection? |
Pawan Kumar Raghav, Sujata Mohanty |
| 338 |
[GO] |
2020―Jun―23 |
COVID-19 as a Viral Functional ACE2 Deficiency Disorder with ACE2 Related Multi-organ Disease |
Rosemary Gan, Nicholas P. Rosoman, David J.E. Henshaw, Euan P. Noble, Peter Georgius, Nigel Sommerfeld |
| 339 |
[GO] |
2020―Jun―23 |
Hypoxemia IN COVID-19 Patients: An Hypothesis |
H.K. Fisher |
| 340 |
[GO] |
2020―Jun―23 |
Towards a pharmacochemical hypothesis of the prophylaxis of SARS-CoV-2 by psychoactive substances |
Hervé Javelot, Julien Petrignet, Frédéric Addiego, Jeanne Briet, Morgane Solis, Wissam El-Hage, Coraline Hingray, Luisa Weiner |
| 341 |
[GO] |
2020―Jun―23 |
Why is SARS-CoV-2 infection more severe in obese men? The gut lymphatics - Lung axis hypothesis |
Mathieu Uzzan, Olivier Corcos, Jerome C. Martin, Xavier Treton, Yoram Bouhnik |
| 342 |
[GO] |
2020―Jun―21 |
Prognostic role of nutritional status in elderly patients hospitalized for COVID-19 |
Guerino Recinella, Giovanni Marasco, Antonia Di Battista, Giampaolo Bianchi, Marco Zoli |
| 343 |
[GO] |
2020―Jun―21 |
Is it Possible to Use Proton Pump Inhibitors in COVID-19 Treatment and Prophylaxis? |
Şeyma Taştemur, Hilmi Ataseven |
| 344 |
[GO] |
2020―Jun―21 |
Pulmonary surfactant itself must be a strong defender against SARS-CoV-2 |
Hideyuki Takano |
| 345 |
[GO] |
2020―Jun―20 |
Plausible role of combination of Chlorpromazine hydrochloride and Teicoplanin against COVID-19 |
NandhaKumar Sathyamoorthy, Pavan Kumar Chintamaneni, Santhivardhan Chinni |
| 346 |
[GO] |
2020―Jun―20 |
Endothelial dysfunction in Coronavirus disease 2019 (COVID-19): gender and age influences |
Guglielmina Froldi, Paola Dorigo |
| 347 |
[GO] |
2020―Jun―19 |
Is periodontal disease a risk factor for severe COVID-19 illness? |
Viviana Pitones-Rubio, EG Chávez-Cortez, Angélica Hurtado-Camarena, Anna González-Rascón, Nicolás Serafín-Higuera |
| 348 |
[GO] |
2020―Jun―19 |
Can COVID-19 induce glioma tumorogenesis through binding cell receptors? |
Imran Khan, Mustafa Aziz Hatiboglu |
| 349 |
[GO] |
2020―Jun―19 |
Targeting Adenosinergic Pathway and Adenosine A2A receptor Signaling for the Treatment of COVID-19: A hypothesis |
Mohamed A. Abouelkhair |
| 350 |
[GO] |
2020―Jun―17 |
Pirfenidone: A novel hypothetical treatment for COVID-19 |
Soroush Seifirad |
| 351 |
[GO] |
2020―Jun―17 |
A physicist's approach to COVID-19 transmission via expiratory droplets |
Pasquale Carelli |
| 352 |
[GO] |
2020―Jun―16 |
WHO statement- “Older people are at highest risk from COVID-19”: Should the hypothesis be corroborated or rejected? |
Ramananda Ningthoujam, Deepa Khomdram |
| 353 |
[GO] |
2020―Jun―15 |
Microvascular Disease Confers Additional Risk to COVID-19 Infection |
Bradley Field Bale, Amy Lynn Doneen, David John Vigerust |
| 354 |
[GO] |
2020―Jun―13 |
A hypothesis about the role of fetal hemoglobin in COVID-19 |
Ehsan Sotoudeh, Houman Sotoudeh |
| 355 |
[GO] |
2020―Jun―11 |
Kawasaki disease shock syndrome or toxic shock syndrome in children and the relationship with COVID-19 |
Michal Pruc, Jacek Smereka, Tomasz Dzieciatkowski, Milosz Jaguszewski, Krzysztof J. Filipiak, Lukasz Szarpak |
| 356 |
[GO] |
2020―Jun―10 |
Endothelial progenitor cells and mesenchymal stem cells to overcome vascular deterioration and cytokine storm in critical patients with COVID-19 |
Fatih Karaahmet, Sinan Altan Kocaman |
| 357 |
[GO] |
2020―Jun―10 |
Aminoglycosides can be a better choice over macrolides in COVID-19 regimen: Plausible mechanism for repurposing strategy |
Nehru Sai Suresh Chalichem, Bharathi Bethapudi, Deepak Mundkinajeddu |
| 358 |
[GO] |
2020―Jun―09 |
Repositioning of pentoxifylline as an immunomodulator and regulator of the renin-angiotensin system in the treatment of COVID-19 |
Valente Maldonado, Marco A. Loza-Mejía, Jaime Chávez-Alderete |
| 359 |
[GO] |
2020―Jun―09 |
Noradrenergic and serotonergic drugs may have opposing effects on COVID-19 cytokine storm and associated psychological effects |
Paul J. Fitzgerald |
| 360 |
[GO] |
2020―Jun―09 |
Respiratory droplets get suspended longer and spread wider in temperate environments compared to tropics and implications for SARS-CoV-2 transmission |
Anusha Rohit, Shankar Rajasekaran, Indrani Karunasagar, Iddya Karunasagar |
| 361 |
[GO] |
2020―Jun―09 |
Increased susceptibility of SARS-CoV2 infection on Oral Cancer patients; Cause and effects: An Hypothesis |
Anshika Chauhan, Sushmita Ghoshal, Arnab Pal |
| 362 |
[GO] |
2020―Jun―08 |
Should aspirin be used for prophylaxis of COVID-19-induced coagulopathy? |
Aliae A.R. Mohamed-Hussein, Karim M.E. Aly, Mohamed-Eltaher A.A. Ibrahim |
| 363 |
[GO] |
2020―Jun―08 |
Occult SARS-CoV-2 Infection; A Possible Hypothesis For Viral Relapse |
Mostafa H. Elberry, Hussien Ahmed |
| 364 |
[GO] |
2020―Jun―07 |
The intriguing commonality of NETosis between COVID-19 & Periodontal disease |
Shipra Gupta, Vaibhav Sahni |
| 365 |
[GO] |
2020―Jun―07 |
Has the chief complaint of patients with COVID-19 disease changed over time? |
Mohammad Dehghani Firouzabadi, Fatemeh Dehghani Firouzabadi, Sogand Goudarzi, Hesam Jahandideh, Maryam Roomiani |
| 366 |
[GO] |
2020―Jun―07 |
Burnout syndrome in Romanian medical residents in time of the COVID-19 pandemic |
Mihai C.T. Dimitriu, Anca Pantea-Stoian, Alexandru C. Smaranda, Anca A. Nica, Alexandru C. Carap, Vlad D. Constantin, Ana M. Davitoiu, Catalin Cirstoveanu, Nicolae Bacalbasa, Ovidiu G. Bratu, Florentina Jacota-Alexe, Cristinel D. Badiu, Catalin G. Smarandache, Bogdan Socea |
| 367 |
[GO] |
2020―Jun―07 |
Could the decrease in the endothelial nitric oxide (NO) production and NO bioavailability be the crucial cause of COVID-19 related deaths? |
Burak Ozdemir, Ahmet Yazici |
| 368 |
[GO] |
2020―Jun―07 |
Deceiving SARS-CoV-2 molecular-tropism clues - A combinational contemporary strategy |
A.P.B. Balaji, Srinivasan Bhuvaneswari, D. Nanda Kumar |
| 369 |
[GO] |
2020―Jun―06 |
Is Hesperidin Essential for Prophylaxis and Treatment of COVID-19 Infection? |
Yusuf A. Haggag, Nahla E. El-Ashmawy, Kamal M. Okasha |
| 370 |
[GO] |
2020―Jun―06 |
A chilblain epidemic during the COVID-19 pandemic. A sign of natural resistance to SARS-CoV-2? |
Dan Lipsker |
| 371 |
[GO] |
2020―Jun―05 |
Intra-abdominal hypertension as a trigger of “gut failure” in SARS-CoV-2 infection: effect of open abdomen (OA) and negative pressure therapy (NPT) on respiratory and gastrointestinal (GI) function |
Pietro Fransvea, Francesco Santullo, Flavio Tirelli, Valeria Fico, Paolo Mirco, Valerio Cozza, Antonio La Greca, Gabriele Sganga |
| 372 |
[GO] |
2020―Jun―05 |
RAGE receptor: May be a potential inflammatory mediator for SARS-COV-2 infection? |
Mohsen Kerkeni, Jawhar Gharbi |
| 373 |
[GO] |
2020―Jun―02 |
B-cell engineering: A promising approach towards vaccine development for COVID-19 |
Muneeb A. Faiq |
| 374 |
[GO] |
2020―Jun―02 |
Nebulized Lidocaine in COVID-19, An Hypothesis |
Ziad A. Ali, Rif S. El-Mallakh |
| 375 |
[GO] |
2020―Jun―02 |
Could nutritional and functional status serve as prognostic factors for COVID-19 in the elderly? |
Irene Lidoriki, Maximos Frountzas, Dimitrios Schizas |
| 376 |
[GO] |
2020―Jun―02 |
The effects of allium sativum on immunity within the scope of COVID-19 infection |
Mustafa Metin Donma, Orkide Donma |
| 377 |
[GO] |
2020―Jun―02 |
Pharmacotherapy for reducing saliva and droplet production in airborne procedures may help to decrease the COVID-19 transmission: a hypothesis |
Ashkan MohammadSadeghi, Iman Karimzadeh, Kamran Bagheri Lankarani, Morteza Banakar |
| 378 |
[GO] |
2020―Jun―01 |
The use of aspirated consonants during speech may increase the transmission of COVID-19 |
Georgios P. Georgiou, Ahmad Kilani |
| 379 |
[GO] |
2020―Jun―01 |
Diacerein: a potential multi-target therapeutic drug for COVID-19 |
Pedro Gonçalves de Oliveira, Lara Termini, Edison Luiz Durigon, Ana Paula Lepique, Andrei C Sposito, Enrique Mario Boccardo Pierulivo |
| 380 |
[GO] |
2020―Jun―01 |
COVID-19 and picotechnology: Potential opportunities |
Navid Rabiee, Mohammad Rabiee, Mojtaba Bagherzadeh, Nima Rezaei |
| 381 |
[GO] |
2020―Jun―01 |
Hydrogen peroxide and viral infections: A literature review with research hypothesis definition in relation to the current covid-19 pandemic |
Arturo Armone Caruso, Antonio Del Prete, Antonio Ivan Lazzarino |
| 382 |
[GO] |
2020―Jun―01 |
COVID-19-related Complications and Decompression Illness Share Main Features. Could the SARS-CoV2-related complications rely on blood foaming ? |
Pierre DENIS |
| 383 |
[GO] |
2020―Jun―01 |
Fighting against frailty and sarcopenia - As well as COVID-19? |
Timur Ekiz, Murat Kara, Levent Özçakar |
| 384 |
[GO] |
2020―Jun―01 |
SARS-CoV-2 and prostatitis: Dangerous relationship for male sexual and reproductive health |
Walter D. Cardona Maya, Alejandro Carvajal |
| 385 |
[GO] |
2020―May―31 |
COVID-19 infection: is the outcome time-dependent? |
Vittorio Pavoni, Lara Gianesello |
| 386 |
[GO] |
2020―May―31 |
Can hyperimmune anti-CMV globuline substitute for convalescent plasma for treatment of COVID-19? |
Basic-Jukic Nikolina |
| 387 |
[GO] |
2020―May―30 |
Antibiotic consumption may be linked to exaggeration of COVID-19 |
Muhammad Asaduzzaman, Farzana Zaman, Emily Rousham |
| 388 |
[GO] |
2020―May―30 |
Neutralizing antibodies mediate virus-immune pathology of COVID-19 |
J.J.L. Jacobs |
| 389 |
[GO] |
2020―May―30 |
COVID-19 & Periodontitis: The cytokine connection |
Vaibhav Sahni, Shipra Gupta |
| 390 |
[GO] |
2020―May―30 |
Mass intake of hydroxychloroquine or chloroquine in the present context of the Covid-19 outbreak: Possible consequences in endemic malaria settings |
Dieudonné M. Mvumbi |
| 391 |
[GO] |
2020―May―30 |
Expression of angiotensin-converting enzyme 2 and proteases in COVID-19 patients: a potential role of cellular FURIN in the pathogenesis of SARS-CoV-2 |
Kinan Drak Alsibai |
| 392 |
[GO] |
2020―May―30 |
Ursodeoxycholic acid as a candidate therapeutic to alleviate and/or prevent COVID-19-associated cytokine storm |
Saleem Abdulrab, Sadeq Al-maweri, Esam Halboub |
| 393 |
[GO] |
2020―May―30 |
Are individuals with cardiovascular disease at risk of COVID-19-related mental health problems or individuals with cardiovascular disease at risk of cardiovascular disease-related mental health problems during COVID-19? A Psychological-Psychiatric Perspective |
Sonia Mukhtar |
| 394 |
[GO] |
2020―May―30 |
Pentoxifylline and complicated COVID-19: A pathophysiologically based treatment proposal |
Stelios F. Assimakopoulos, Fotios Seintis, Markos Marangos |
| 395 |
[GO] |
2020―May―30 |
What would sérgio ferreira say to your physician in this war against COVID-19: How about kallikrein/kinin system? |
Lucas A.D. Nicolau, Pedro J.C. Magalhães, Mariana L. Vale |
| 396 |
[GO] |
2020―May―30 |
Diabetes and severity of COVID-19: What is the link? |
D. Pitocco, L. Viti, L. Tartaglione, M. Di Leo, G.E. Rizzo, A. Manto, A. Rizzi, S. Caputo, A. Pontecorvi |
| 397 |
[GO] |
2020―May―30 |
Could Autism Spectrum Disorders be a Risk Factor for COVID-19? |
Matheus Eugênio de Sousa Lima, Levi Coelho Maia Barros, Gislei Frota Aragão |
| 398 |
[GO] |
2020―May―30 |
Ribosomal proteins as a possible tool for blocking SARS-COV 2 virus replication for a potential prospective treatment |
Marian Rofeal, Fady Abd El-Malek |
| 399 |
[GO] |
2020―May―30 |
N-Acetylcysteine: a potential therapeutic agent for SARS-CoV-2 |
Francis L. Poe, Joshua Corn |
| 400 |
[GO] |
2020―May―30 |
Novel therapeutic targets for SARS-CoV-2-induced acute lung injury: targeting a potential IL-1β/Neutrophil Extracellular Traps feedback loop |
Ahmed Yaqinuddin, Junaid Kashir |
| 401 |
[GO] |
2020―May―30 |
Periodontal pockets: A potential reservoir for SARS-CoV-2? |
Zahi Badran, Alexis Gaudin, Xavier Struillou, Gilles Amador, Assem Soueidan |
| 402 |
[GO] |
2020―May―29 |
MDA5 should be detected in severe COVID-19 patients |
Qiang Xu |
| 403 |
[GO] |
2020―May―29 |
COVID-19: Thinking about further mental and neurological disorders |
Renato Sobral Monteiro-Junior |
| 404 |
[GO] |
2020―May―29 |
Persistent SARS-CoV-2 infection and the risk for cancer |
Miguel Alpalhão, João Augusto Ferreira, Paulo Filipe |
| 405 |
[GO] |
2020―May―28 |
Could MEFV mutation carriage status have a protective role for COVID-19 pandemia? |
Salih Kavukçu, Alper Soylu |
| 406 |
[GO] |
2020―May―27 |
The association between obesity and poor outcome after COVID-19 indicates a potential therapeutic role for montelukast |
Muhammad Qutayba Almerie, David Daniel Kerrigan |
| 407 |
[GO] |
2020―May―27 |
Activated macrophages are the main inflammatory cell in COVID-19 interstitial pneumonia infiltrates. Is it possible to show their metabolic activity and thus the grade of inflammatory burden with 18F-Fluorocholine PET/CT? |
G. Savelli, M. Bonacina, A. Rizzo, A. Zaniboni |
| 408 |
[GO] |
2020―May―27 |
Immunopharmacological management of COVID-19: Potential therapeutic role of valproic acid |
Gokhan Unal, Bahadir Turan, Yasin Hasan Balcioglu |
| 409 |
[GO] |
2020―May―27 |
Is there enough evidence to discontinue the renin-angiotensin system inhibitors in patients with COVID-19? |
Irina Bobkova, Elena Kamyshova, Tatiana Rudenko, Ekaterina Stavrovskaya, Sergey Moiseev |
| 410 |
[GO] |
2020―May―26 |
Protective effects of vaccinations and endemic infections on COVID-19: A hypothesis |
Ramachandran Meenakshisundaram, Subramanian Senthilkumaran, Ponniah Thirumalaikolundusubramanian |
| 411 |
[GO] |
2020―May―26 |
Is anosmia the price to pay in an immune-induced scorched-earth policy against COVID-19? |
S.D. Le Bon, M. Horoi |
| 412 |
[GO] |
2020―May―25 |
Potential Role of Zinc Supplementation in Prophylaxis and Treatment of COVID-19 |
Amit Kumar, Yuichi Kubota, Mikhail Chernov, Hidetoshi Kasuya |
| 413 |
[GO] |
2020―May―25 |
The Use of Ibuprofen to Treat Fever in COVID-19: A Possible Indirect Association with Worse Outcome? |
Brenda Jamerson, T. Ho Haryadi |
| 414 |
[GO] |
2020―May―24 |
Selenium supplementation in the prevention of coronavirus infections (COVID-19) |
Marek Kieliszek, Boguslaw Lipinski |
| 415 |
[GO] |
2020―May―24 |
Genetic variation in SARS-CoV-2 may explain variable severity of COVID-19 |
Subrata K Biswas, Sonchita R Mudi |
| 416 |
[GO] |
2020―May―24 |
A new pharmacological approach based on remdesivir aerosolized administration on sars-cov-2 pulmonary inflammation: a possible and rational therapeutic application |
Carlo Contini, Carla Enrica Gallenga, Gianpiero Neri, Martina Maritati, Pio Conti |
| 417 |
[GO] |
2020―May―23 |
Iodine, a preventive and curative agent in the COVID-19 pandemic? |
R.H. Verheesen, R.A.M. Traksel |
| 418 |
[GO] |
2020―May―23 |
Survival of COVID-19 patients requires precise immune regulation: The hypothetical immunoprotective role of nicotinic agonists |
M. Allahverdi Khani, M. SalehiRad, S. Darbeheshti, M. Motaghinejad |
| 419 |
[GO] |
2020―May―23 |
Covid-19: loss of bridging between innate and adaptive immunity? |
Vishal Rao, Gururaj Arakeri, Anand Subash, Jyothsna Rao, Sachin Jadhav, Mufti Suhail Sayeed, Gururaj Rao, Peter A. Brennan |
| 420 |
[GO] |
2020―May―23 |
A potential role for cyclophosphamide in the mitigation of acute respiratory distress syndrome among patients with SARS-CoV-2 |
Swaroop Revannasiddaiah, Santhosh Kumar Devadas, Rasmi Palassery, Nirdosh Kumar Pant, Vinayak V Maka |
| 421 |
[GO] |
2020―May―23 |
Zinc Iodide in combination with Dimethyl Sulfoxide for treatment of SARS-CoV-2 and other viral infections |
Ba X Hoang, Huy Q Hoang |
| 422 |
[GO] |
2020―May―22 |
COVID-19 Cytokine Storm and Novel Truth |
Sherif Sultan, Mohamed Sultan |
| 423 |
[GO] |
2020―May―22 |
Three Novel Prevention, Diagnostic and Treatment Options for COVID-19 Urgently Necessitating Controlled Randomized Trials |
Richard I. Horowitz, Phyllis R. Freeman |
| 424 |
[GO] |
2020―May―22 |
Hypothesis for the management and treatment of the COVID-19-induced acute respiratory distress syndrome and lung injury using mesenchymal stem cell-derived exosomes |
Mahsa Taghavi-farahabadi, Mohammad Mahmoudi, Sara Soudi, Seyed Mahmoud Hashemi |
| 425 |
[GO] |
2020―May―21 |
Homocysteine as a potential predictor of cardiovascular risk in patients with COVID-19 |
Giovanni Ponti, Cristel Ruini, Aldo Tomasi |
| 426 |
[GO] |
2020―May―20 |
Use of Hydroxychloroquine and Interferon alpha-2b for the Prophylaxis of COVID-19 |
Alexander Yang, Charlotte Yang, Bing Yang |
| 427 |
[GO] |
2020―May―20 |
Hypoxia Inducible Factor-1 Protects Against COVID-19: A Hypothesis |
Baris Afsar, Mehmet Kanbay, Rengin Elsurer Afsar |
| 428 |
[GO] |
2020―May―20 |
Can moderate intensity aerobic exercise be an effective and valuable therapy in preventing and controlling the pandemic of COVID-19? |
Snehil Dixit |
| 429 |
[GO] |
2020―May―19 |
Sodium Chromo-Glycate and Palmitoylethanolamide: a Possible Strategy to Treat Mast Cell-induced Lung Inflammation in COVID-19 |
Antonio Gigante, Alberto Aquili, Luca Farinelli, Alessandro Caraffa, Gianpaolo Ronconi, Carla Enrica Gallenga, Giulia Tetè, Spyros K. Kritas, Pio Conti |
| 430 |
[GO] |
2020―May―19 |
May COVID-19 outbreaks lead to a worsening of skin chronic inflammatory conditions? |
Claudio Marasca, Angelo Ruggiero, Maddalena Napolitano, Gabriella Fabbrocini, Matteo Megna |
| 431 |
[GO] |
2020―May―19 |
COVID-19, quarantine, and atopic dermatitis |
Cataldo Patruno, Steven Paul Nisticò, Gabriella Fabbrocini, Maddalena Napolitano |
| 432 |
[GO] |
2020―May―18 |
Is the anti-filarial drug diethylcarbamazine useful to treat COVID-19 ? |
Anuruddha Abeygunasekera, Saroj Jayasinghe |
| 433 |
[GO] |
2020―May―18 |
Covid-19 disease will cause a global catastrophe in terms of mental health: A hypothesis |
Delia Izaguirre-Torres, Raúl Siche |
| 434 |
[GO] |
2020―May―16 |
Bioactive compounds with possible inhibitory activity of Angiotensin-Converting Enzyme-II; a gate to manage and prevent COVID-19 |
Farid Dabaghian, Mahnaz Khanavi, Mohammad M. Zarshenas |
| 435 |
[GO] |
2020―May―16 |
Protective potential of Expectorants against COVID-19 |
Zohreh Esam |
| 436 |
[GO] |
2020―May―16 |
The Effect of Potential Therapeutic Agents on QT Interval in Patients with COVID-19 Infection: The Importance of Close Monitoring and Correction of Electrolytes |
Parham Habibzadeh, Mohsen Moghadami, Kamran Bagheri Lankarani |
| 437 |
[GO] |
2020―May―15 |
Reflection on lower rates of COVID-19 in children: does childhood immunizations offer unexpected protection? |
Jinglu Lyu, Tianyu Miao, Jiajia Dong, Ranran Cao, Yan Li, Qianming Chen |
| 438 |
[GO] |
2020―May―12 |
Do pets protect their owners in the COVID-19 era? |
Jan Jurgiel, Krzysztof J. Filipiak, Łukasz Szarpak, Miłosz Jaguszewski, Jacek Smerka, Tomasz Dzieciątkowski |
| 439 |
[GO] |
2020―May―12 |
Cytokine Storm: Is it the only major death factor in COVID-19 patients? Coagulation role |
Giuseppe Magro |
| 440 |
[GO] |
2020―May―12 |
Exercise as medicine for COVID-19: An ACE in the hole? |
Kevin S. Heffernan, Sae Young Jae |
| 441 |
[GO] |
2020―May―12 |
COVID-19: beta-thalassemia subjects immunised? |
Edouard Lansiaux, Philippe Pierre Pébaÿ, Jean-Laurent Picard, Joachim Son-Forget |
| 442 |
[GO] |
2020―May―11 |
As a potential treatment of COVID-19: Montelukast |
Cihan Fidan, Ayşe Aydoğdu |
| 443 |
[GO] |
2020―May―08 |
Etoposid-based therapy for severe forms of COVID-19 |
Kamel Hamizi, Souhila Aouidane, Ghania Belaaloui |
| 444 |
[GO] |
2020―May―07 |
Covid-19 management with Inflammation Resolving Mediators? Perspectives and Potential |
Pedro-Antonio Regidor |
| 445 |
[GO] |
2020―May―07 |
Lithium for the 2019 novel coronavirus |
Germán Gómez-Bernal |
| 446 |
[GO] |
2020―May―07 |
What about the original antigenic sin of the humans versus SARS-CoV-2? |
Luca Roncati, Beniamino Palmieri |
| 447 |
[GO] |
2020―May―06 |
Genetic predisposition models to COVID-19 infection |
Farzaneh Darbeheshti, Nima Rezaei |
| 448 |
[GO] |
2020―May―06 |
Relation between BCG coverage rate and COVID-19 infection worldwide |
A. Macedo, C. Febra |
| 449 |
[GO] |
2020―May―06 |
Does zinc supplementation enhance the clinical efficacy of chloroquine/hydroxychloroquine to win todays battle against COVID-19? |
R. Derwand, M. Scholz |
| 450 |
[GO] |
2020―May―05 |
Free DNA, a reason for severe COVID-19 infection? |
Bin Liu |
| 451 |
[GO] |
2020―May―05 |
Is copper beneficial for COVID-19 patients? |
Syamal Raha, Rahul Mallick, Sanjay Basak, Asim K. Duttaroy |
| 452 |
[GO] |
2020―May―05 |
The role of ACEIs/ARBs in COVID-19: friend or foe? |
Zhe Zhou, Yumin Qiu, Jun Tao |
| 453 |
[GO] |
2020―May―05 |
Can beta-adrenergic blockers be used in the treatment of COVID-19? |
Natesan Vasanthakumar |
| 454 |
[GO] |
2020―May―01 |
COVID-19 AND AUTISM |
Gary Steinman |
| 455 |
[GO] |
2020―May―01 |
Lithium chloride combination with rapamycin for the treatment of COVID-19 pneumonia |
Rami Bou Khalil |
| 456 |
[GO] |
2020―Apr―29 |
Is it fair to hope that patients with Type 1 Diabetes (autoimmune) may be spared by the infection of Covid-19? |
Patrizio Tatti, Giancarlo Tonolo, Angela Zanfardino, Dario Iafusco |
| 457 |
[GO] |
2020―Apr―27 |
Mesenchymal stem cell (MSc) secretome: A possible therapeutic strategy for intensive-care COVID-19 patients |
Elenice Deffune, Aruã Prudenciatti, Andrei Moroz |
| 458 |
[GO] |
2020―Apr―27 |
The puzzle of sharing bio-molecular targets between coronaviruses and mediators of the cardiovascular system in humans: Looking for plausible hypotheses |
Michele M. Ciulla |
| 459 |
[GO] |
2020―Apr―27 |
Hydroxychloroquine as an aerosol might markedly reduce and even prevent severe clinical symptoms after SARS-CoV-2 infection |
A. Klimke, G. Hefner, B. Will, U. Voss |
| 460 |
[GO] |
2020―Apr―27 |
Why not consider an endothelin receptor antagonist against SARS-CoV-2? |
S. Javor, A. Salsano |
| 461 |
[GO] |
2020―Apr―25 |
Amantadine as a drug to mitigate the effects of COVID-19 |
Gonzalo Emiliano Aranda Abreu, María Elena Hernández Aguilar, Deissy Herrera Covarrubias, Fausto Rojas Durán |
| 462 |
[GO] |
2020―Apr―25 |
Loop mediated isothermal amplification (LAMP) assays as a rapid diagnostic for COVID-19 |
Junaid Kashir, Ahmed Yaqinuddin |
| 463 |
[GO] |
2020―Apr―25 |
Airborne route and bad use of ventilation systems as non-negligible factors in SARS-CoV-2 transmission |
G. Correia, L. Rodrigues, M. Gameiro da Silva, T. Gonçalves |
| 464 |
[GO] |
2020―Apr―24 |
Two simple comments regarding coronavirus |
Emanuel Gluskin |
| 465 |
[GO] |
2020―Apr―24 |
Does infection of 2019 novel coronavirus cause acute and/or chronic sialadenitis? |
Chenxing Wang, Heming Wu, Xu Ding, Huan Ji, Pengfei Jiao, Haiyang Song, Sheng Li, Hongming Du |
| 466 |
[GO] |
2020―Apr―24 |
Serum albumin-mediated strategy for the effective targeting of SARS-CoV-2 |
Pushpendra Mani Mishra, Vladimir N. Uversky, Chayan K. Nandi |
| 467 |
[GO] |
2020―Apr―23 |
The possible beneficial adjuvant effect of Influenza vaccine to minimize the severity of COVID-19 |
Mohamed Labib Salem, Dina El-Hennawy |
| 468 |
[GO] |
2020―Apr―23 |
Potential effect of natural and anabolizan steroids in elderly patient with COVID-19 |
Fatih Karaahmet, Ozgur Zeliha Karaahmet |
| 469 |
[GO] |
2020―Apr―23 |
Plausible mechanisms of Niclosamide as an antiviral agent against COVID-19 |
Sai Kiran S.S. Pindiprolu, Sai Harshini Pindiprolu |
| 470 |
[GO] |
2020―Apr―23 |
Purposing Saikosaponins for the treatment of COVID-19 |
Eshak I. Bahbah, Ahmed Negida, Mohamed Salah Nabet |
| 471 |
[GO] |
2020―Apr―23 |
COVID-19 and anosmia in Tehran, Iran |
Sapideh Gilani, Rachel Roditi, Mohsen Naraghi |
| 472 |
[GO] |
2020―Apr―23 |
Dapsone, colchicine and olanzapine as treatment adjuncts to prevent COVID-19 associated adult respiratory distress syndrome (ARDS) |
Eric L. Altschuler, Richard E. Kast |
| 473 |
[GO] |
2020―Apr―23 |
COVIDiagnosis-Net: Deep Bayes-SqueezeNet based diagnosis of the coronavirus disease 2019 (COVID-19) from X-ray images |
Ferhat Ucar, Deniz Korkmaz |
| 474 |
[GO] |
2020―Apr―23 |
2019-nCoV-SARS-CoV-2 (COVID-19) Infectıon: Crucıalıty of Furın and Relevance wıth Cancer |
Cigdem Usul Afsar |
| 475 |
[GO] |
2020―Apr―23 |
5-Fluorouracil in combination with deoxyribonucleosides and deoxyribose as possible therapeutic options for the Coronavirus, COVID-19 infection |
S.I. Ahmad |
| 476 |
[GO] |
2020―Apr―23 |
Innate immunity in COVID-19 patients mediated by NKG2A receptors, and potential treatment using Monalizumab, Cholroquine, and antiviral agents |
Ahmed Yaqinuddin, Junaid Kashir |
| 477 |
[GO] |
2020―Apr―23 |
Covid-19, TMPRSS2, and whether android regulation affects pandemic virus gender incidence and age distribution of disease |
Steven R. Brenner |
| 478 |
[GO] |
2020―Apr―23 |
COVID-19 type III hypersensitivity reaction |
Batool Mutar Mahdi |
| 479 |
[GO] |
2020―Apr―23 |
N-acetyl-cysteine may prevent COVID-19-associated cytokine storm and acute respiratory distress syndrome |
Stelios F. Assimakopoulos, Markos Marangos |
| 480 |
[GO] |
2020―Apr―23 |
Suggesting Ritonavir against COVID-19/SARS-CoV-2 |
Shuvasish Choudhury, Muhammed Khairujjaman Mazumder |
| 481 |
[GO] |
2020―Apr―23 |
Vitamin D: A simpler alternative to tocilizumab for trial in COVID-19? |
Morry Silberstein |
| 482 |
[GO] |
2020―Apr―23 |
Phytotherapeutics and SARS-CoV-2 infection: Potential role of bioflavonoids |
M.D. Maurizio Coppola, M.D. Raffaella Mondola |
| 483 |
[GO] |
2020―Apr―23 |
A data-driven hypothesis on the epigenetic dysregulation of host metabolism by SARS coronaviral infection: potential implications for the SARS-CoV-2 modus operandi |
George D. Vavougios |
| 484 |
[GO] |
2020―Apr―22 |
Dapsone and doxycycline could be potential treatment modalities for COVID-19 |
Ahmed Farouk, Samar Salman |
| 485 |
[GO] |
2020―Apr―22 |
Respiratory conditions in coronavirus disease 2019 (COVID-19): Important considerations regarding novel treatment strategies to reduce mortality |
Mark R. Geier, David A. Geier |
| 486 |
[GO] |
2020―Apr―22 |
May patients receiving 5-alpha-reductase inhibitors be in higher risk of COVID-19 complications? |
Jan Adamowicz, Kajetan Juszczak, Tomasz Drewa |
| 487 |
[GO] |
2020―Apr―22 |
Hypothesized behavioral host manipulation by SARS-CoV2 / COVID-19 infection |
Michael C. Barton, Kaylee V. Bennett, John R. Cook, Gordon G. Gallup, Steven M. Platek |
| 488 |
[GO] |
2020―Apr―22 |
May IL-17 have a role in COVID-19 infection? |
Matteo Megna, Maddalena Napolitano, Gabriella Fabbrocini |
| 489 |
[GO] |
2020―Apr―22 |
Is Coronavirus Disease 2019 (COVID-19) seen less in countries more exposed to Malaria? |
Gokhan Sargin, Sare İlknur Yavaşoğlu, Irfan Yavasoglu |
| 490 |
[GO] |
2020―Apr―22 |
The Powerful Immune System Against Powerful COVID-19: A Hypothesis |
Farzad Taghizadeh-Hesary, Hassan Akbari |
| 491 |
[GO] |
2020―Apr―22 |
Can pioglitazone be potentially useful therapeutically in treating patients with covid-19? |
Elena Carboni, Anna R. Carta, Ezio Carboni |
| 492 |
[GO] |
2020―Apr―20 |
The old but new: Can unfractioned heparin and low molecular weight heparins inhibit proteolytic activation and cellular internalization of SARS-CoV2 by inhibition of host cell proteases? |
F.B. Belen-Apak, F. Sarialioglu |
| 493 |
[GO] |
2020―Apr―06 |
WITHDRAWN: Is global BCG vaccination coverage relevant to the progression of SARS-CoV-2 pandemic? |
Mayda Gursel, Ihsan Gursel |
| 494 |
[GO] |
2020―Mar―26 |
Hyperglycemia and the novel Covid-19 infection: Possible pathophysiologic mechanisms |
Ioannis Ilias, Lina Zabuliene |
| 495 |
[GO] |
2020―Mar―25 |
Routine childhood immunization may protect against COVID-19 |
Samar Salman, Mohamed Labib Salem |
| 496 |
[GO] |
2020―Mar―21 |
Renin-angiotensin system: The unexpected flaw inside the human immune system revealed by SARS-CoV-2 |
Luca Roncati, Graziana Gallo, Antonio Manenti, Beniamino Palmieri |
